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foreword
The Academy of Science of South Africa (ASSAf) has a mandate to provide evidence-based 
scientific advice to South African policymakers and this consensus report is in fulfilment of this 
mandate. 
South Africa is one of only very few African countries that has commercialised GMOs. 
A plethora of recent developments in genetic engineering and related technologies has 
necessitated the reassessment of their possible value, biosafety implications and regulation. 
This led the Department of Science and Technology (DST) to commission this study by ASSAf. 
This study had two main objectives: to make sure South African policy appropriately and 
adequately addresses biosafety requirements of these new techniques to ensure safe and 
sustainable research, development and use of their products; and to ensure the regulatory 
requirements are appropriate to the technologies and/or their products. 
This consensus report provides an overview of the so-called new breeding techniques (NBTs), 
as well as an overview of current global approaches to the regulation of these NBTs and then 
makes recommendations on: 
•	  how to assess these new and future techniques and their products regarding their possible 
subjection to existing GMO legislation;
•	  how current biosafety policy and regulations may need to be amended to accommodate 
the varying biosafety implications of these products; 
•	  if current risk analysis frameworks and practice are sufficient to assess the biosafety of these 
products.
This report is the product of the voluntary work of a six-member consensus study panel and I 
would like to extend appreciation to them, especially the chairperson, Dr Hennie Groenewald, 
for expert contributions and the production of this important and timely report. 
The report was peer-reviewed by three experts: Dr Jane Morris, Prof Diran Makinde and Prof 
Stuart Smyth.
I hope the recommendations will be implemented in a manner that will benefit biotechnology 
in the country. 
Appreciation is also extended to all Academy staff, personnel, stakeholders and researchers 
who contributed to this study and the writing of the report. 
Funding from the Department of Science and Technology is also hereby gratefully acknowl-
edged. 
Professor Jonathan Jansen 
President: Academy of Science of South Africa
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definiTions
Allele A variant form of a gene.
Biosafety General: The efforts and mechanisms to assess, manage and 
communicate the potential risks resulting from biotechnology 
and its products and in particular GMOs.
GMO Act: The level of safety when risk management 
measures must be taken to avoid potential risk to human 
and animal health and safety and to the conservation of the 
environment, as a result of exposure to activities with GMOs.
Cas A CRISPR associated protein.
Chimeric gene A gene formed from a combination of portions of one or 
more coding sequences to produce new genes. These 
mutations are distinct from fusion genes which merge whole 
gene sequences into a single reading frame and often retain 
their original functions.
Chromosome A thread-like structure of nucleic acids and protein found in 
the nucleus of most living cells, carrying genetic information 
in the form of genes.
Cisgene An intact, functional gene sequence that occurs naturally in 
a target organism or a sexually compatible species, including 
its natural regulatory cis-sequences such as its promoter and 
terminator.
Cpf1 A single RNA-guided endonuclease of a class 2 CRISPR-Cas 
system.
crRNA A small trans-encoded RNA.
Epigenetic Cellular and physiological phenotypic trait variations that 
are caused by external or environmental factors that switch 
genes on and off and affect how cells ‘read’ genes instead 
of being caused by changes in the DNA sequence.
Episome A DNA molecule that replicates independently of chromosomal 
DNA, e.g. a plasmid.
Eukaryotic An organism whose cells contain a nucleus surrounded by a 
membrane and whose DNA is bound together by proteins 
(histones) into chromosomes.
Exogenous (biology) Originating from outside an organism.
Gene A distinct sequence of nucleotides, the order of which 
determines its function, and which is the basic unit of heredity 
that is transferred from a parent to offspring and is held to 
determine some characteristic of the offspring. In general, 
includes appropriate regulatory sequences such as promoters 
and terminator sequences. 
THE REGULATORY IMPLICATIONS OF NEW BREEDING TECHNIQUES 11
Gene drive Refers to a genetic element that promotes the inheritance 
of a particular allele/gene to increase its prevalence in a 
population (also used to describe the practice of inducing 
such non-Mendelian inheritance).
Gene therapy A technique for delivering functional genes (to replace 
aberrant ones) into living cells by means of a genetically 
modified vector or by physical means in order to genetically 
alter the living cell (from GMO Act).
Genetic engineering The deliberate process of design, editing and/or assembly 
of genetic sequences aimed at changing the genetic 
characteristics of living organisms.
Note: The terms “genetic engineering” and “genetic modifi-
cation” are often used interchangeably. In this document the 
term “genetic engineering” is used in a more general context 
to refer to related techniques and processes, while “genetic 
modification” is use in accordance with its legal definition in 
the GMO Act, which relates more directly to a ‘modified or-
ganism’.
Genetic trait A characteristic such as size, shape, taste, colour, increased 
yields, or disease resistance – also referred to, individually or 
combined, as phenotype.
Genetically modified organism 
(GMO)
An organism, the genes or genetic material of which, have 
been modified in a way that does not occur naturally through 
mating or natural recombination or both, and 'genetic 
modification' has a corresponding meaning (from GMO Act).
Note: Also see “genetic engineering”.
Genome The entire complement of hereditary material in a cell.
Genome editing The precise modification of the nucleotide sequence of a 
genome.
Genotype The genetic makeup of an organism or group of organisms 
with reference to a single trait, a set of traits, or an entire 
complex of traits.
Harm Suffering injury, damage, loss, or any adverse effect.
Hazard (i.t.o. GMOs) An intrinsic biological, chemical or physical characteristic 
of a genetically modified organism which could lead to an 
adverse impact on the environment (from GMO Act).
Hazard, harm & risk summary                    Exposure
Hazard                           Harm
Probability of harm occurring = risk = (likelihood x 
consequence).
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Heterologous genes A gene or part of a gene in a host organism, which does not 
naturally have this gene or gene fragment.
Note: also see transgene and exogenous.
Indel A small insertion or deletion in a DNA sequence.
Meiosis Cell division that produces reproductive cells (gametes) in 
sexually reproducing organisms – the nucleus divides into four 
nuclei each containing half the chromosome number (n), as 
opposed to diploid (2n), somatic cells with two sets (one each 
from each parent).
miRNA Micro RNA – are small non-coding RNA molecules (containing 
about 22 nucleotides) which have regulatory functions.
Modern biotechnology The application of in vitro nucleic acid techniques, including 
recombinant DNA and direct injection of nucleic acid into 
cells or organelles or fusion of cells beyond the taxonomic 
family. 
New breeding techniques A non-specific collective name for a wide and evolving 
range of techniques aimed at modifying genomes and/or 
gene expression.
Null segregant Offspring in which the GM element used to engineer the 
parent organism has been removed through conventional 
breeding (GM traits are only used transiently).
Open Reading Frame Part of a gene that has the potential to code for a protein or 
peptide.
Organism A biological entity, cellular or non-cellular, capable of me-
tabolism, replication, reproduction or of transferring genetic 
material and includes micro-organisms.
Phenotype The set of, or a specific, observable characteristic(s) of an 
individual organism resulting from the interaction of its geno-
type with the environment.
Pleiotropic When one gene influences two or more seemingly unrelated 
phenotypic traits.
Prokaryote A unicellular organism that lacks a distinct cell nucleus and 
the DNA is not organised into chromosomes. It also lacks the 
internal structures bound by membranes called organelles, 
such as mitochondria.
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Recombinant DNA technology A series of procedures that are used to join together 
(recombine) DNA segments. A recombinant DNA molecule 
is constructed from segments of two or more different DNA 
molecules.
Reverse breeding A novel breeding technique designed to produce homologous 
parental lines for a superior heterozygous plant. Subsequent 
hybridisation of the obtained homozygous parental lines will 
reconstitute the original superior heterozygous line. 
Risk The probability of causing or incurring a loss or damage or an 
adverse impact or a misfortune (i.e. a harm). 
Risk assessment A structured, reasoned process, based on the analysis of sci-
entific evidence, for considering the likelihood and conse-
quence of harm occurring.
Risk perception The subjective judgement that people make about the 
characteristics and severity of a risk.
Risk management The evaluation of whether the risks identified by the risk 
assessment process are acceptable and manageable, 
then selecting and implementing the control measures as 
appropriate to ensure that risks are minimised or controlled.
RNA interference RNA interference, or RNAi, refers to a set of biological process-
es that makes use of native cellular machinery to silence gene 
expression. Although there are several variations in the source 
and mechanism, they are all triggered by double-stranded 
RNA (dsRNA), with a sequence complementary to the gene 
targeted for silencing, which is processed by a protein com-
plex into small, single stranded RNAs, i.e. small interfering RNA 
(siRNA).
Synthetic biology A modern biotechnological approach that combines science, 
technology and engineering to facilitate the understanding, 
redesign, and/or modification of existing biological systems 
and components or the design and manufacture of new 
biological systems and components, based on the selective 
and purposeful use of genetic material. The application of 
synthetic biology principles results in novel biological systems 
and/or components thereof, including living organisms, cells, 
bio-molecules, pathways and/or assemblages thereof.
Transgene A heterologous gene that has been artificially inserted into 
the genome of an organism.
14 THE REGULATORY IMPLICATIONS OF NEW BREEDING TECHNIQUES
exeCuTive 
summary
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“New breeding techniques” (NBTs) are a wide and evolving range of techniques aimed at 
modifying genomes and/or gene expression and using these in particular ways on a whole-
organism level. It is becoming increasingly evident that these techniques hold great potential 
benefit in plant, animal and microbial breeding programmes. Indeed, the accessibility and 
utility of these techniques have already led to the commercialisation of the first products 
developed using these techniques. The conceptual and technical similarities and/or overlaps 
between these NBTs and genetic modification (GM) technology, which is regulated, have 
therefore initiated an international discussion on the regulatory status of these techniques and/
or their products. There is an urgent need to reach conclusions that will ensure the safety and 
sustainability of research, development and commercialisation work in this area as the field 
is developing rapidly. At the same time, it is important that regulations do not unintentionally 
inhibit innovation in the biotechnology sector.
This consensus study therefore examined the possible regulatory implications of NBTs within 
the South African context by considering the following:
•	 The relevance of NBTs to the South African biotechnology sector.
•	 The possible biosafety implications of NBTs.
•	 The possible fit (or differentiated fit) of these techniques and/or their products with 
existing GMO legislation.
•	 The robustness of the current biosafety risk analysis frameworks to accommodate these 
and possible future techniques and their products.
•	 The need for the GMO Act and its regulations to adapt in order to accommodate 
current and possible future genome modifying technologies.
The most critical findings of this study were:
•	  NBTs is a non-specific collective name for a wide and evolving range of techniques 
aimed at modifying genomes and/or gene expression, which have great potential as 
they allow the relatively quick, efficient, accurate and cost-effective modification of 
valuable genetic traits in crops, livestock and industrial microbes. These include gene ed-
iting techniques, null segregants, variations on genetic modification and transgrafting.
•	  Internationally, only Argentina has published an official, national framework on how to 
regulate the products of these techniques. In addition, in countries such as Canada, 
which has a strong product-base regulatory trigger, there is no need to make technique 
/process-based amendments. It is evident that the great majority of authors and 
organisations, who have considered this issue, consider the principle of case-by-case 
decision-making as an important component of any framework.
•	  When dealing with any type of genome modification, the principal source of risk, i.e. 
hazard, is the organism whose genome has been changed, i.e. the product, and not 
the process or techniques through which these changes were induced. This resulting 
product should therefore be the trigger and subject of regulation, i.e. risk management 
practices, and the regulatory requirements should be proportional to the possible risks it 
poses. 
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•	 South Africa has a robust and experienced regulatory system for GMOs, which can 
without much change be applied to also effectively regulate the products of these new 
techniques and, in fact, any genome modifying techniques that may still be developed 
in the future. The key for allowing this is that the GMO Act (Act15 of 1997), as it stands, 
o has a product-based trigger, 
o sets genetic variation beyond that which may also occur naturally as the threshold 
for regulation.
•	 Applying the suggested framework will result in the products of NBTs simply being 
classified as either GMOs, which will be regulated under the GMO Act as per usual, 
or non-GMOs that will not be subject to regulation under this Act. The introduction of 
a succinct ‘notification procedure’ will ensure a mechanism allowing case-by-case 
decisions and appropriate oversight.
•	 The likely regulatory outcomes of the suggested framework are very well aligned with 
the currently available consensus discussions of other international risk assessment and 
relevant regulatory experts. Its implementation will ensure effective and appropriate 
oversight to ensure the safety and sustainability of all relevant products, without unduly 
impacting on innovation.
• Finally, it is also important to note that this study has NOT considered in detail all the 
possible practical regulatory and legal implications of the scientific recommendations 
made here, as these are the prerogative of the relevant regulators and therefore 
fall outside the mandate and expertise of this panel. All relevant technical legal and 
practical regulatory issues therefore still have to be considered by the appropriate 
authorities, including legal opinion on the science-based interpretation of definitions 
and associated implications, alignment with the Cartagena Protocol on Biosafety and 
international harmonisation.
This consensus study panel is of the opinion that the implementation of the recommendations 
contained in this report will provide effective and appropriate oversight to ensure the safety 
and sustainability of all relevant products, without unduly impacting on bio-innovation as 
encouraged in the Bioeconomy Strategy. It can also be implemented relatively quickly and 
easily, because it is based on established legislation. Finally, although very few countries 
have officially implemented NBT regulations, the likely regulatory outcomes of the proposed 
approach align very well with the consensus discussions of other international experts.
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ChapTer 1
introduction 
and background
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1.1 Introduction
Recent scientific and technological advances have led to the development of new 
techniques in animal, plant and microbial breeding, jointly referred to as new breeding 
techniques (NBTs). In turn, this has led to discussions as to whether these techniques may 
result in products that are subject to the regulatory framework applicable to genetically 
modified organisms (GMOs). Since South Africa is in the process of developing an official 
position with regard to the possible regulatory status of NBTs, it will be valuable to review 
the most commonly used NBTs, the national and relevant international frameworks for the 
regulation of GMOs and other countries’ approaches to this issue, to provide insight into the 
possible regulatory status and approaches to these NBTs and their products.
The technologies originally used to develop transgenics – using viral vectors, T-DNA plasmids 
or “biolistics”/“gene guns” – were relatively crude techniques and were the most common 
methods for performing direct genetic modification when South Africa’s GMO Act (Act 15 
of 1997) was written. Since then molecular biology has developed a variety of new genome 
modification techniques. These include various tools for genome editing (such as zinc-finger 
nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and, in particular, 
clustered regularly-interspersed short palindromic repeats (CRISPR) that are more precise 
and predictable.
Consideration of new biotechnologies and the possible regulatory measures to which they 
may be subject is a necessary and ongoing process for three main reasons: 
•	 to consider the possible evolving biosafety implications of these new techniques; 
•	  to reflect on how regulatory frameworks may have to adapt to accommodate possible 
new products and/or techniques to ensure their sustainable development and use; 
•	  to help ensure South Africa benefits from appropriate new biotechnologies that could 
make the country more competitive, create sustainable jobs, enhance food security 
and create a greener economy as contemplated in the National Government’s Bio-
economy Strategy of 2013 (pp 6 – 8).
Given its role of providing objective, evidence-based scientific advice to the South African 
government and increasing public awareness of science, the Academy of Science of South 
Africa (ASSAf) is well placed to meet the challenge of providing objective advice on NBTs. 
This consensus study could also be used as a valuable guide by regulators and policymakers 
in other African countries on how to make informed decisions on the development, 
introduction and use of NBTs.
1.2  Background
Plant breeding started more than 10 000 years ago when farmers began to select and 
multiply the best plants in their fields. Farmers domesticated crops through the continued 
selection and breeding of desirable traits. A major breakthrough in plant breeding occurred 
in 1865, when Gregor Mendel presented the results of his experiments on plant hybridisation 
at two meetings of the Natural History Society of Brno in Moravia. His discovery of the laws of 
genetics and the process of cross-breeding was followed by hybrid breeding in the 1930s, 
tissue and cell culture methods in the 1960s and recombinant DNA techniques and genetic 
engineering in the 1980s. However, the development of each subsequent new technique 
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has not resulted in the older breeding methods being abandoned – in fact modern plant 
and animal breeders still use the full range of breeding techniques available to achieve 
their goals. 
Plant breeding makes use of the natural variation in plant genomes which is an essential 
driver for plants to adapt to their changing environments. This variation has resulted in a wide 
variety of crops with a long history of safe use. Modern varieties of maize, wheat and rice are 
dramatic examples of the end result of human selection on agricultural crops. Improvement 
of the most desirable agronomic and yield enhancing traits has resulted in crop varieties that 
are safe, robust, and capable of growing under a wide range of environmental conditions
In addition, the use of advanced breeding techniques such as mutagenesis, ploidy 
manipulation and somatic hybridisation has introduced more useful genetic variation. 
Mutation breeding alone, which introduces additional genetic variation via radiation or 
chemical mutagenesis, has resulted in the development of more than 3 200 improved crop 
varieties, which have been safely cultivated and consumed over the past 100 years. This 
long history of safe use of plant varieties produced by exploiting their natural endogenous 
and inducible endogenous genetic variation has demonstrated that the application of 
these techniques does not pose inherent safety hazards and they have therefore not been 
regulated. 
The development of genetic engineering (GE) techniques for the first time enabled the 
routine transfer of genetic material across the sexual compatibility barrier. Consequently, 
the introduction of the first genetically modified (GM) crops in the early 1990s raised novel 
biosafety questions that subjected these products to specific regulations aimed at ensuring 
their food and feed safety, environmental safety and eventually even their socio-economic 
viability before they are commercially produced. 
New risk analysis methods had to be developed to analyse these complex, living systems, 
as previous risk assessment methodologies were based on simple single compound, dose-
effects. GMO risk analysis has evolved over the past 20 years into an effective tool based 
on the contextualised, comparative analysis of these organisms and their products; taking 
the nature of the introduced genetic sequences (the trait(s)), the characteristics of the crop 
and the receiving environment into consideration. Again, the absence of any documented 
evidence of unexpected adverse effects caused by GM crops over the past 20 years 
confirms the above conclusion that the exploitation of genetic potential is not inherently 
dangerous when applied in conjunction with robust regulatory and risk analysis frameworks.
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THe HISTory of GMo reGulATIon
The development of a regulatory framework for genetic engineering began in 1975 at 
Asilomar, California. The first recombinant DNA techniques had just been developed 
and the scientific community recognised that apart from its benefits, this technology 
could also pose some risks to the environment and human health. The Asilomar meeting 
recommended a set of guidelines for the safe use of recombinant technology and any 
products produced by it. Initially, the Asilomar recommendations were voluntary, but in 
1976, the United States of America’s (USA) National Institute of Health (NIH) formed a rDNA 
advisory committee to regulate the technology.
In 1982, as the first transgenic plants were being developed, the Organisation for Economic 
Co-operation and Development (OECD) released a report on the potential hazards of 
releasing GMOs into the environment. The USA established a committee at the Office of 
Science and Technology Policy (OSTP) to develop mechanisms to regulate the developing 
technology and in 1986, the OSTP assigned regulatory approval of genetically modified 
plants in the USA to the United States Department of Agriculture (USDA), Environmental 
Protection Agency (EPA) and Food and Drug Administration (FDA) (OSTP, 1992). 
South Africa’s GMO regulatory system has its origins in the now defunct South African 
Committee on Genetic Experimentation (SAGENE), initiated and led by the research 
community, which governed research and development (R&D) on GMOs from 1979. 
SAGENE was, for example, mandated in 1987 to advise on the possible effects of release 
into the environment of organisms with recombinant DNA (Government Gazette No 
10535, Notice 532). The South African biosafety regulatory framework was formalised in 
1999 in the form of the GMO Act (Act 15 of 1997), which allowed South Africa to be 
an early adopter of GM technology, with the first commercial planting of a GM crop in 
1998. The Act and regulations have since been amended (2006) to accommodate the 
provisions of the Cartagena Protocol on Biosafety and the overall biosafety regulatory 
system expanded to include aspects regulated under health, environmental and trade 
legislation.
On 29 January 2000, the Conference of the Parties to the Convention on Biological Diversity 
adopted a supplementary agreement to the Convention known as the Cartagena 
Protocol on Biosafety. This Protocol is an international treaty that governs the transfer, 
handling, and use of GMOs. 170 countries, including South Africa, are now Parties to the 
Protocol and many use it as a reference point for their own GM legislation.
Until recently, whether a new product was considered a GMO, and therefore regulated, 
or not, was a relatively simple matter for regulators and biotechnology developers. Non-
GMOs were obtained by some or other historical breeding technique, which only exploits 
endogenous genetic potential – collectively classified as “conventional breeding” – while a 
GMO was defined as an organism that possessed a novel combination of genetic material, i.e. 
includes heterologous genetic material, obtained through the use of modern biotechnology. 
In the South African context (the GMO Act), GMOs were defined as “organisms the genetic 
material of which has been modified in a way that does not occur naturally” to introduce 
“unnatural genetic variation” as the threshold for regulation. The more recent development 
of the so-called “new breeding techniques” (NBTs) that started in the late 1990s with the use 
of molecular markers, genome mapping and sequencing, has however blurred these lines 
somewhat.
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NBTs is a non-specific collective name for a wide, evolving and expanding range of tech-
niques aimed at modifying genomes and gene expression, and which are based on the 
advances made in genetics and molecular biology research and technology developments 
over the past 20 years. They can be used to introduce, remove or modify desired genetic 
traits more precisely and in less time than with conventional breeding or first-generation GM-
technology in a wide variety of organisms. The end result of these interventions can range 
from small insertions and deletions, indistinguishable from those that may occur naturally, to 
the introduction of multiple exogenous genes. Some of these techniques hold huge poten-
tial benefit as they would allow the relatively quick, efficient, accurate and cost-effective 
modification of valuable genetic traits in crops, livestock, industrial micro-organisms, etc. – 
improving on many of the negative aspects associated with both conventional breeding 
and first-generation GM-technology. This will allow the breeding programmes of less affluent 
organisations, such as those in the public sector, and those for small, locally-relevant crops, 
livestock, etc. access to a technology that has the potential to be transformative, especially 
within a developing world context.
Unfortunately, the current lack of clarity on what regulatory control may be applicable to 
(some) NBTs is hampering investment in their development and application. Even in countries 
that do have functioning GMO policy and regulatory frameworks in place, the handling of 
these techniques and their products is not clear-cut, due to their diverse and varied nature. 
The great majority of countries are still debating the issue internally and have not yet drawn 
policy conclusions or established possible regulatory criteria. To date, only Argentina has 
formalised its regulatory approach to NBTs as (i) “triggered by the novel combination of 
genetic material” (and then regulated as a GMO) and (ii) “handled on a case-by-case basis” 
(to allow an acceptable level of flexibility while technologies evolve) (Whelan and Lema, 
2015).
It is very important that the possible regulation of NBTs is considered as a matter of urgency 
and that countries worldwide harmonise their approach to this challenge. Harmonisation is 
necessary to prevent arbitrary decisions from creating regional and international asymmetries 
in scientific and technical development and barriers to trade that will limit farmers’ and 
consumers’ access to new opportunities and products. It should also be appreciated that 
disjointed and excessive regulatory approaches can impact risk perceptions, unduly raise 
public concern and negatively impact the application of beneficial technologies. Broad-
brush regulation and oversight based on technique/process only, could result in undue, 
costly regulatory burdens, stifle innovation and prevent the uptake of scientifically advanced, 
innovative breeding applications by the public and private sectors. Due consideration should 
therefore be given to the actual source and the contextualised magnitude of potential risk 
when considering the regulation of NBTs.
1.2.1 Approach and Methodology
This study on regulatory implications of new genetic engineering technologies was 
commissioned by the DST. A six-member panel, chaired by Dr Hennie Groenewald, was 
appointed by the ASSAf Council to undertake the study. Biographies of the panel members 
are attached as Appendix 1. The panel was supported in its investigations by a researcher, Dr 
Dave Keetch, of Goldamer Consulting. 
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The study was conducted between May 2015 and January 2017. A consultative workshop 
was held on 11 October 2016 in Pretoria. The workshop was attended by 22 key stakeholders 
from different organisations/institutions and government departments (See Appendix 2). The 
workshop discussions enriched this study.
The final draft report was submitted for peer review in mid-January 2017. Following the 
peer-review process by three experts, Dr Jane Morris of Morris Life Science Consulting, Prof 
Diran Makinde of African Biosafety Network of Expertise (ABNE) and Prof Stuart Smyth of the 
University of Saskatchewan Canada, the panel finalised the report and it was approved by 
the Executive Committee of the ASSAf Council in March 2017.
Panel Membership
Panel Members Affiliated Organisations/Institutions
Dr Hennie Groenewald Biosafety South Africa, Technology Innovation Agency
Dr Eugenia Barros Council for Scientific and Industrial Research (CSIR)
Dr Kingston Mashingaidze Agricultural Research Council (ARC)
Prof Iqbal Parker University of Cape Town (UCT)
Dr James Southern Retired and Independent Consultant 
1.2.2 Rationale for Study
The rationale for the study stems from recent scientific and technological advances that 
have led to the development of multiple new technologies involving genetic modification 
(GM) and the need to ensure that appropriate policies and regulations are in place to 
address biosafety requirements. 
Originally, the technologies developed to perform genetic engineering – using viral vectors, 
T-DNA plasmids or ‘biolistics’/‘gene guns’ – were relatively crude techniques and were the 
most common methods for performing direct genetic modification when the South African 
GMO Act (Act 15 of 1997) was written. The conceptual approach underpinning the Act 
was ‘substantial equivalence’, i.e. not being substantially different from the non-modified 
counterpart.
Since the emergence of recombinant DNA technology in the 1990s, molecular biology has 
developed a variety of new genetic modification techniques. These include various tools 
for genome editing such as zinc-finger nucleases (ZFNs), transcription activator-like effector 
nucleases (TALENs) and, in particular, clustered regularly interspersed short palindromic 
repeats (CRISPR) that are even more precise and predictable.
The consideration of regulatory controls for new technologies is thus a necessary and 
ongoing process for two main reasons:
•	 to identify the possible biosafety implications (“risks”) of these new techniques;  
•	  to ensure the regulatory requirements are appropriate to the technologies and/or 
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products so as not to unduly constrain research, development and use of these products 
in South Africa. 
Given its role of providing objective, evidence-based scientific advice to the South African 
government and increasing public awareness of science, ASSAf is well placed to meet 
the challenge of providing objective advice on biosafety implications and appropriate 
policy responses. This consensus study could also be used as a valuable guide by regulators 
and policymakers in other African countries on how to make informed decisions on the 
development, introduction and use of these new technologies.
1.2.3 Study Brief
The terms of reference of the study were to:
•	 Consider the relevance of NBTs to the South African biotechnology sector.
•	 Interrogate the possible biosafety implications of NBTs.
•	  Determine their fit with the existing GMO Act, specifying which of these new techniques 
and/or their products should fall under the GMO Act and which should not.
•	  Determine the robustness of current biosafety risk analysis frameworks to accommodate 
these new techniques and their products.
•	  Provide recommendations on how the GMO Act and its regulations may have to adapt to 
be able to accommodate current and possible future genome modifying technologies.
Topics that were considered and deemed to fall outside the scope of this study, for the 
reasons provided, are as follows:
•	 The ethics related to the application of NBTs
  All biotechnology research, development and application are already subject to well-
established ethics frameworks. As NBTs were considered to not present any immediate 
novel ethical implication, irrespective of the nature of any regulatory recommendations 
that may emanate from this study, it was decided to focus on the regulatory implications 
only.
•	 Synthetic biology
  Although the regulation of synthetic biology is also currently discussed internationally, its 
goals, techniques and products are significantly different from those of NBTs and was 
therefore not considered. In addition, current applications are all clearly subject to existing 
GMO regulatory frameworks
•	 Gene drives
  A gene drive is a designed outcome of a genetic intervention at a population level, 
rather than a genetic modification technique per se. It is also targeted at wild populations 
and not at domesticated or industrial organisms. Finally, current gene drive techniques 
necessitate the use of heterologous gene sequences, which subject these organisms to 
GMO regulation.
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ChapTer 2
The evolution of Crop 
breeding Techniques
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2.1 Introduction 
It is widely believed that all foods developed by conventional breeding are ‘natural’ and ‘safe’ 
and, unlike GM foods, have not been modified by human intervention. However, genetic 
and phenotypic modification of food began as soon as humans started domesticating plants 
many thousands of years ago. Early farmers started saving seeds from plants that demonstrated 
useful traits such as size, taste, resistance to pests and disease and yield. Selected crops were 
then further improved by cross-breeding with related species, mutational breeding and/or 
hybridisation, which resulted in large-scale changes to the respective crops’ genomes. As a 
result, none of the plant-based foods that we eat today existed in their current form before 
humans intervened and they have very little in common with the foods consumed by society 
many thousands of years ago. For example, wild maize was bred from a grass called Teosinte 
that originated in southern Mexico. Teosinte is composed of about a dozen small seeds in hard 
shells which are unpalatable. Wild potatoes originated from South America and were thin 
finger-like tubers with a bitter taste. Similarly, cauliflower, broccoli, kale, Brussels sprouts and 
cabbage have all been bred from wild mustard plants found in the northern Mediterranean 
region.
A brief, chronological overview of various crop breeding techniques follows to give some 
insights into the relevant underlying principles, constraints, impacts and evolution of mankind’s 
endeavours to modify the traits, and the underlying genomes, of crop plants over the ages.
2.2 Conventional Breeding 
 Regulatory Status: ExEMPT FROM REGULATION
The breakthrough that enabled modern plant breeding occurred in 1865, when Gregor Mendel 
presented the results of his experiments on plant hybridisation at two meetings of the Natural 
History Society of Brno in Moravia. His discovery of the laws of genetics and the process of 
cross-breeding formed the basis of conventional breeding. In principle, parents with desirable 
traits are selected and crossed to yield offspring with variable combinations of those traits. 
Mendel’s laws of segregation and independent assortment help breeders to understand the 
genetic principles behind their phenotypic observations and enabled them to breed crop 
plant varieties with desired traits more effectively. Because conventional breeding depends 
on sexual reproduction, its application is principally limited to sexually compatible individuals. 
Exploitable genetic potential is therefore limited to the natural endogenous genetic variation 
within closely related species that can interbreed. Genetic linkage, i.e. the fact that some 
genes are physically connected to each other, also results in a situation where ‘beneficial’ 
and ‘detrimental’ traits cannot always be separated from each other. 
2.3 Hybrid Seed Technology
 Regulatory status: ExEMPT FROM REGULATION
Hybrid seed development was one of the main contributors to the dramatic rise in agricultural 
output during the last half of the 20th century and is based on the fact that plant crops, 
highly heterozygous for desired traits, perform very well. Elite, inbred parent lines that are 
highly homologous for desirable traits are developed and then crossed to produce a highly 
heterozygous, uniform population of F1 hybrid seed. Hybrids were used to dramatically 
improve crop traits such as yield, resistance to pests and diseases, grain uniformity, colour 
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and time to maturity. Producing hybrids that are commercially viable can take many years 
to achieve but the end results can be impressive. Maize hybrids have been developed that 
together with improved farming practices have more than tripled maize grain yields over 
the past 50 years, while hybrid rice offers the possibility of increasing rice yields by up to 20%.
2.4 Mutation Breeding, Ploidy Manipulation and Hybridisation
 Regulatory status: ExEMPT FROM REGULATION
Random mutations in genomes are a source of natural genetic variation, but these occur 
only at very low frequency. Plant breeders have therefore developed techniques, e.g. ex-
posure to high-energy radiation or certain chemicals such as sodium azide and ethyl meth-
anesulphonate, to artificially induce random mutations, which may, in turn, result in desired 
phenotype changes. These techniques were popular in the 1940s when plants were exposed 
to a variety of radiation sources to induce random mutations in an attempt to produce more 
useful traits. Although generally considered to be a technique with very low efficiency, these 
mutation techniques are still being used today – of the approximately 2 300 officially released 
mutation breeding varieties, almost half have been released over the past 15 years. Crops as 
diverse as ruby grapefruit, rice, sunflowers and pears have benefited from mutation breeding.
Ploidy refers to the number of sets of chromosomes in a cell. Gametes or germ cells, i.e. egg 
cells, sperm and pollen, are haploid – containing a single copy of each chromosome or a 
single full set of chromosomes. Consequently, when two gametes fuse during fertilisation, 
the newly formed zygote and all subsequent somatic cells will contain two copies of each 
chromosome and are therefore diploid. Manipulation of the ploidy number during breeding 
can yield organisms with multiple copies of its chromosomes, e.g. tetraploids (four copies, 
for example cotton) and hexaploids (six copies, for example wheat), with a wide variety of 
improved traits. Triploid (three copies) organisms are usually infertile because of their unequal 
number of chromosomes and have yielded products such as seedless watermelons and 
bananas.
Hybridisation generally refers to the breeding of two genetically distinct individuals, e.g. different 
breeds, varieties, species or genera, which usually results in offspring with a high degree of 
heterozygosity. Hybridisation breeding is often used to increase the genetic variation within a 
breeding population by crossing individuals with different genetic backgrounds, but which are 
still compatible. Plant tissue culture techniques have also made cellular hybridisation possible, 
which allows for the hybridisation of even more distantly related individuals via protoplast 
fusion and subsequent regeneration.
2.5 Marker-Assisted Selection (MAS)
 Regulatory status: ExEMPT FROM REGULATION
Molecular markers are breeding tools that are particularly valuable for selecting recessive 
or stacked traits where phenotypic selection is not practically possible, e.g. multiple resistant 
genes cannot be selected for when the phenotypes overlap. A molecular maker is an arbitrary 
fragment of genetic material that can be ‘genetically linked’ to a specific genetic trait, i.e. 
it segregates with the trait since it is physically linked to the gene(s) of interest. The theory is 
that if the molecular marker is present then the desired gene(s) and therefore the trait is also 
present. For example, more than 40 genes that provide resistance to major tomato diseases 
have already been identified and through the use of MAS, this has resulted in a large selection 
of tomato varieties with resistance or tolerance to several pathogens.
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2.6 Recombinant DNA Technology and Genetically Modified Organisms (GMOs)
 Regulatory status: REGULATED
Traditionally, a plant breeder exchanges genes between two sexually compatible plants to 
produce offspring that have desired traits – a male (pollen) haploid genome is combined with 
a female (egg cell) haploid genome during fertilisation to produce a new, genetically unique, 
diploid individual. This cross breeding, however, is limited to exchanges between the same or 
very closely related species; always resulting in a lot of variability because two complete 
genomes are integrated and undesirable traits may be linked to desirable ones.
Recombinant DNA technology allows the isolation and multiplication of individual genes 
(cloning), their pairing with selected regulatory sequences (recombination) and the transfer 
of such a functional genetic unit to a living plant cell (transformation), which can then be 
developed (regenerated) into a new, transgenic plant. These transgenic, or GM individuals 
then have a phenotype consistent with that of the original recipient plant plus the additional 
trait encoded for by the new transgene. GM technology enables plant breeders to introduce 
genes from any living organisms into crop plants, irrespective of their sexual compatibility. It is 
therefore a very powerful breeding tool that allows plant breeders to generate superior plant 
varieties with trait combinations beyond the limits imposed by conventional plant breeding. 
SeleCTeD HIGHlIGHTS of THe IMPACT of GM CroPS
An analysis of 147 studies over the last 20 years reported that “on average, GM technology 
adoption has reduced chemical pesticide use by 37%, increased crop yields by 22%, and 
increased farmer profits by 68%”. These findings are supported by the results of other global 
studies. From 1996 to 2014, biotech crops contributed to food security, sustainability and 
the reduction of environmental impact by: increasing crop production valued at US$150 
billion; providing a better environment by saving 584 million kg of pesticides; reducing CO2 
emissions; conserving biodiversity by saving 152 million ha of land from cultivation; and 
helped alleviate poverty for ~16.5 million resource-poor farmers and their families totalling 
~65 million people.
Source: ISAAA Brief 51-2015: Top Ten Facts about Biotech/GM Crops in their First 20 Years,1996 to 2015.
The continued development and use of genetic engineering technologies in research and 
development has also led to the discovery and elucidation of many biological processes, 
which now form the basis for biotechnology innovations. RNA interference, or RNAi, in 
particular, is one such process with huge potential application. It refers to a collection of 
biological processes that makes use of native cellular machinery to silence gene expression. 
Although there are several variations in the source and mechanism, they are all triggered 
by double-stranded RNA (dsRNA), with a sequence complementary to the gene targeted 
for silencing. The ability to specifically down-regulate gene expression has many potential 
applications and has already been used to develop novel crops such as nicotine-free tobacco, 
decaffeinated coffee, nutrient-fortified and hypoallergenic crops and the commercially 
released low-acrylamide potatoes and non-browning apples. 
In 1994, Calgene’s delayed-ripening tomato (Flavr-Savr™) became the first GM food crop to 
be produced and consumed. Today, GM varieties of maize, cotton, soybean and canola are 
planted by 18 million farmers in 28 countries and on 180 million hectares per annum. Ninety 
per cent of these farmers are resource-poor farmers in developing countries.
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2.7 Genome editing 
 Regulatory status: UNDETERMINED
Genome editing refers to the precise modification of the nucleotide sequence of a genome 
and forms part of the so-called NBTs. Genome editing techniques started to develop in the 
late 1990s with the discovery of homing and zinc-finger endonucleases, which can direct DNA 
cleavage to very specific sites within a genome. While GM transformation techniques such 
as Agrobacterium and particle gun-mediated gene transfer depend on the random insertion 
of the transgene into the genome, the newly developed genome editing tools can direct 
insertions, replacements or deletions to specific sites within the genome. The site-specificity of 
these nucleases is achieved through sequence-specific protein-DNA or DNA-DNA interactions. 
The three main genome editing tools that are currently being used are ZFNs, TALENs and 
the clustered regularly interspaced short palindromic repeats/Cas9 nuclease system (CRISPR/
Cas). These tools can be used to replace an aberrant gene sequence, delete specific 
sequences, introduce mutations, including base substitutions, insertions and deletion, or to 
insert new genes. Genome editing interventions can therefore result in widely different genetic 
outcomes, including some that are indistinguishable from those that can occur naturally. 
2.8 Synthetic Biology 
 Regulatory status: UNDETERMINED
Its novelty, multi-disciplinarity and integrated nature and current, limited application results 
in synthetic biology being a vaguely defined entity. Little international consensus exists 
regarding the character and scope of synthetic biology and there is no universally acceptable 
definition. What is clear though is that synthetic biology is not a technique or tool, but rather a 
modern biotechnological approach that combines science, technology and engineering to 
facilitate the understanding, redesign, and/or modification of existing biological systems and 
components or the design and manufacture of new biological systems and components, 
based on the selective and purposeful use of genetic material. The application of synthetic 
biology principles results in novel biological systems and/or components thereof, including 
living organisms, cells, bio-molecules, pathways and/or assemblages thereof.
One of the goals of synthetic biology is the preparation of viable minimal genomes which will 
function as platforms for the biochemical production of chemicals with economic value. The 
production of biofuels, pharmaceuticals and the bioremediation of environmental pollution 
are expected to constitute the first commercial applications of this new technique. As a first 
step towards this goal, the genome of Mycoplasma genitalium, the smallest known bacterial 
genome, was assembled from commercially synthesised pieces in 2010 (Gibson et al., 2010). 
Theoretically, the principles and tools of synthetic biology can be used to develop a wide 
spectrum of possible products, from simple in vitro biological pathways, originating from 
natural biological systems to completely artificial organisms. It is therefore not possible to 
consider/manage/regulate ‘synthetic biology’ effectively as a single entity. It is possible 
products will have to be grouped based on more relevant considerations and managed 
as such, i.e. a product-based approach. Moreover, there is at least some overlap between 
synthetic biology’s possible products and those from other breeding techniques as discussed 
above. Synthetic biology will therefore also not form part of the further work of this consensus 
study.
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2.9 Conclusion
The techniques used to breed new varieties of plants and animals have evolved over many 
thousands of years from the simple selection and multiplication of naturally occurring genetic 
variation, through hybridisation, mutation breeding, marker-assisted selection, recombina-
tion DNA technology (GMOs) and more recently, genome editing. More recently developed 
techniques also increased the speed, accuracy and scope of genetic variation induction. 
During this evolutionary process, only GMOs have been subjected to strict regulatory control. 
Stakeholders must now consider to what extent the recently developed NBTs and/or their 
products should be regulated or excluded from regulation.
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ChapTer 3
overview of new 
breeding Techniques 
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3.1 Introduction
Some variants of the techniques mentioned here are standard for the genetic modification 
of plants, animals and micro-organisms, although the term NBT is currently seldom used 
beyond plant breeding because of:
•	  the regulatory debate on the relationship of NBTs to plant products and GM plants which 
is more developed and sophisticated; 
•	  the increasing quantity and variety of such products continually being submitted to 
regulatory authorities worldwide for evaluation.
Nevertheless, it is important to note that in most cases, regulatory frameworks begin with the 
same definition of GMOs irrespective of the biological kingdom.
As defined before, the term NBTs is a non-specific collective name for a wide and evolving 
range of techniques and approaches aimed at modifying genomes and gene expression. 
NBTs can be divided into the following three, non-exclusive categories:
(1) Genome Editing/Targeted Mutagenesis
Site-directed nucleases (SDNs)
SDNs, often also referred to as sequence-specific nuclease (SSN), use naturally occurring 
endonucleases to generate a double-strand break at an exact pre-defined location in the 
DNA. The subsequent repair of the break can then be directed to create a variety of tar-
geted DNA sequence modifications, ranging from small deletions to the insertion of genes. 
SDN applications can be divided into three types: 
In SDN-1 no donor DNA template is supplied that forces non-homologous end-joining (NHEJ), 
enabled by the naturally occurring DNA repair mechanisms. In most cases NHEJ introduces 
small insertions or deletions (indels) that lead to a loss in gene function, i.e. targeted gene 
knockouts. 
In SDN-2 applications, a homologous donor DNA template, which is a copy of the target 
gene sequence with only a small modification, is used. During repair, this homologous, 
modified sequence will be introduced into the genome, causing a targeted mutation, 
which could restore or modify gene function.
SDN-3 applications are similar to SDN-2 applications, except that in this case the homologous 
donor DNA includes (a) complete gene sequence(s) – these could be cis-, intra- and/or 
transgene sequences. SDN-2 and 3 therefore enable targeted gene knock-ins. 
Four main engineered nuclease families or ‘SDN tools’ have been developed, namely:
a) Zinc-Finger Nucleases (ZFNs).
b) Meganucleases (MNs).
c) Transcription activator-like effector nucleases (TALENs).
d)  Clustered regularly interspaced short palindromic repeats/Cas9 nuclease system 
(CRISPR/Cas).
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Oligonucleotide-directed mutagenesis
An oligonucleotide (a small single strand DNA molecule) with a desirable point mutation, 
similar to the SND-2 donor DNA, is introduced into an animal cell or plant protoplast and 
incorporated into the target gene via the native DNA repair mechanisms of the cell.
 
(2) Null (Negative) Segregants:
A genetically modified ‘intermediate’ plant is used in the breeding process, but the progeny 
released is lacking the transgene/GM event, e.g. reverse breeding, early flowering, etc.
RNA-dependent DNA Methylation (RdDM) in which the released variety inherits an 
epigenetic modification, but not any heterologous gene sequences.
(3) Variants of Genetic Transformation
Cisgenesis – the DNA sequence inserted into the modified plant is an unchanged sequence 
found in the same species or from a sexually compatible species; usually refers to a complete, 
functional sequence including the native regulatory and gene sequences.
Intragenesis – DNA inserted into the modified plant is re-organised or is used in new 
combinations, but still from the same species or from a ‘crossable’ species.
Transgrafting – non-GM scion grafting onto GM rootstocks or vice versa.
Gene DrIveS
The breeding techniques discussed here introduce new genetic variation that will be 
inherited as normal by subsequent generations and should be clearly distinguished from 
gene drives. A gene drive is a genetic element (and the practice of using it) that alters 
the inheritance patterns of a particular allele/gene to favour its inheritance and thereby 
increase its prevalence in the population, even if that gene reduces the fitness of individual 
organisms. 
Gene drives can for example be used to prevent the spread of insects that carry diseases, 
e.g. mosquitoes that transmit malaria, dengue and Zika, control invasive species, or 
eliminate herbicide or pesticide resistance. Since gene drives function only in sexually 
reproducing species, they cannot be used to engineer populations of viruses or bacteria.
Current gene drive techniques necessitate the use of heterologous gene sequences, 
which will subject these organisms to the GMO Act, but because gene drives are primarily 
aimed at changing the genetic composition of wild populations, i.e. the genetic trait is 
designed to become pervasive, their potential impact has raised many bioethical and risk 
concerns. The application of gene drives was therefore deemed to fall outside the scope 
of this study and not considered.
3.2 Genome editing: Site-Directed nucleases (SDns)
These are a set of techniques based on the use of nucleases that introduce a break in the 
DNA helix near a defined target sequence. After the break is introduced the DNA repair 
mechanisms and, in some cases, the use of additional nucleic acid sequences, result in 
different kinds of site-specific modifications. These range from the deletion of a few nucleotides 
to the insertion of additional sequences. For example, ZFNs, MNs, TALENs and CRISPR.
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3.2.1 Zinc-Finger Nucleases (ZFNs) 
ZFNs are artificial restriction enzymes generated by fusing two domains, i.e. a zinc-finger DNA 
binding domain and a catalytic nuclease domain. The zinc-finger binding domain typically 
constitutes of several zinc-finger protein repeats that each recognise three bases of DNA. 
Because individual zinc-finger repeats can be engineered to recognise any specific three 
base pair sequence, the complete binding domain, which contains three to six of these zinc- 
fingers, can be engineered to specifically target any unique sequence in a genome. Typically, 
the non-specific type IIs restriction endonuclease Fok I is fused to the binding domain to act as 
the cleavage domain for ZFNs. 
A ZFN-induced double-strand break (DSB) allows a range of possible alleles to be generated 
at endogenous loci as illustrated in Figure 3.1 from Urnov et al. (2010). The DSB generated by 
ZFN cleavage induces endogenous DNA repair processes that may be influenced by the 
absence or addition of repair template DNA. If the break is repaired via non-homologous 
end joining (NHEJ), i.e. in the absence of repair template DNA, the target gene can be 
disrupted due to small insertions or deletions, a tag can be inserted or a large deletion can be 
introduced via two simultaneous, adjacent DSBs (left-hand side of Fig 3.1). In contrast, if the DSB 
is repaired via homology-directed repair (HDR), i.e. in the presence of repair template DNA, 
this can result in gene correction due to small mutations, the insertion of a single transgene or 
transgene stacking (right-hand side of Fig 3.1).
figure 3.1 Types of genome editing made possible using zinc-finger nucleases (from Urnov et al. 2010)
3.2.2 Meganucleases (MNs)
MNs are endodeoxyribonucleases characterised by a large recognition site (double-stranded 
DNA sequences of 12 to 40 base pairs); as a result this site generally occurs only once in any 
given genome. MNs are, therefore, considered to be the most specific naturally occurring 
restriction enzymes.
Among the MNs, the LAGLIDADG family of homing endonucleases has become a valuable 
tool for the study of genomes and genome engineering over the past 15 years. MNs are 
‘molecular DNA scissors’ that can be used to replace, eliminate or modify sequences in a 
highly targeted way. By modifying their recognition sequence through protein engineering, 
the targeted sequence can be changed. MNs are used to modify all genome types, whether 
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bacterial, plant or animal. They open up wide avenues for innovation, particularly in the 
field of human health, for example the elimination of viral genetic material or the ‘repair’ of 
damaged genes using gene therapy (Honig et al., 2015).
3.2.3 Transcription Activator-like Effector Nucleases (TALENs)
TALENs are restriction enzymes that can be engineered to cut specific sequences of DNA. 
They are made by fusing a TAL effector DNA-binding domain to a DNA cleavage domain 
(a nuclease which cuts DNA strands). Transcription activator-like effectors (TALEs) can be 
engineered to bind practically any desired DNA sequence, so when combined with a 
nuclease, DNA can be cut at specific locations (Christian et al., 2010).The restriction enzymes 
can be introduced into cells, for use in gene editing or for genome editing in situ, a technique 
known as genome editing with engineered nucleases.
3.2.4 CRISPR-Cas9 Systems
CRISPR (clustered regularly interspaced short palindromic repeats) and Cas (CRISPR-associ-
ated) genes are responsible for adaptive immune responses in some prokaryotes, enabling 
the organisms to eliminate invading genetic material, e.g. bacteriophages. Three types of 
CRISPR mechanisms have been identified, of which type II, e.g. the Cas9 system, has been 
studied in most detail. In principle, invading DNA is recognised, cut into small pieces and in-
tegrated into the CRISPR locus from where it is subsequently transcribed in combination with 
associated small RNAs (trRNA and crRNA), which facilitate sequence specific targeting and 
association with the Cas9 endonuclease. This RNA/endonuclease complex (CRISPR-Cas9) 
has the ability to specifically recognise invading DNA based on sequence complementarity 
and subsequently cleave the target DNA (Fig. 3.2) – a system analogous to RNA-interfer-
ence in eukaryotic organisms (Jinek et al., 2012).
figure 3.2 Schematic representation of the steps in a CRISPR-Cas9 adaptive immune response (https://
www.neb.com)
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The simplicity of the type II CRISPR-Cas9 system, with only three required components (Cas9, 
trRNA and crRNA), makes it amenable to adaptation for genome editing. In fact, it has 
already been simplified to a two-component system by combining the trRNA and crRNA 
molecules in a synthetic, single guide RNA (gRNA). 
Similar to what was discussed for ZFNs, CRIPR-Cas9 can be used to induce site-specific 
double-stranded DNA breaks (DSBs), which can subsequently be repaired by the cellular 
non-homologous end joining (NHEJ) mechanisms, resulting in small insertions and/or deletions 
(indels), which could disrupt the targeted locus (Shan et al., 2013). Alternatively, if a donor 
template with homology to the targeted locus is supplied, the DSB may be repaired via 
homology-directed repair (HDR), allowing for precise replacement mutations or the insertion 
of heterologous gene sequences (Fig. 3.3).
figure 3.3 Types of genome editing made possible using CRISPR-Cas9 (http://toolgen.com)
The accuracy, flexibility, simplicity, relative low cost and efficiency of the CRISPR-Cas9 system 
has led to its wide adoption. It has already been successfully used to target important genes 
in a wide range of cell lines and organisms. The CRISPR-Cas9 system requires only the redesign 
of the crRNA to change target specificity, which contrasts with other genome editing tools, 
including ZFNs and TALENs, where redesign of the protein-DNA interface is also required. 
The introduction of small mutations (indels and base substitutions) and heterologous genes 
into a specific target gene, via a single guide RNA (gRNA) is now routine and pairs of gRNA-
directed Cas9 nucleases can be used to induce large deletions or genomic rearrangements, 
such as inversions or translocations. More recent developments also use a nuclease-deficient 
Cas9 version to modulate transcriptional regulation and epigenetic modification and also 
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for the microscopic visualisation of specific genome loci. It is therefore clear that the CRISPR-
Cas9-based tools hold great potential, not only for basic research, but also for improving 
the genetic traits of crops and domesticated animals, other industrial organisms and for 
treating disease.
3.2.5 Possible Risks Associated with SDNs 
IMPorTAnT ConSIDerATIonS
Before contemplating the broad possible biosafety risks that may be associated with all 
the techniques discussed in this chapter, two critically important contextual considerations 
should be explained. 
(1)  As discussed in subsequent chapters the actual source of risk, i.e. the hazard, in terms of 
GMOs is the modified organism and not the technique through which it was generated. 
It is therefore impossible to do a sensible, comprehensive risk analysis on a technique 
alone. This is further supported by the fact that the resulting GM trait of a modified 
organism is a critical input for both the food and feed safety and environmental risk 
assessments done on GMOs. Finally, because a single technique can be used to 
induce a wide variety of different traits and/or genetic changes, the only possible 
risks that may be directly associated with a particular technique, are limited to those 
associated with its molecular mechanisms and can at best be discussed comparatively 
to other techniques.
(2)  The potential risks associated with NBTs should always be considered within an 
appropriate context, i.e. taking, amongst others, the following into consideration:
•	  compare the associated molecular mechanisms, e.g. their accuracy and efficiency, 
with the natural mechanisms responsible for inducing genetic variation;
•	  compare the induced changes with similar genetic variation and unintended effects 
that may occur during natural sexual reproduction;
•	  take past experiences with the risk assessment of GMOs into account; 
•	  distinguish theoretical risks from those potentially present in a regenerated, healthy-
looking whole organism.
Possible risks of SDNs will be associated with the specific methods used to introduce the 
molecular components into the targeted organism or the methods used to regenerate 
organisms from the modified cells. However, with these technologies, the required proteins 
are usually expressed in trans (originate from a transient expression system) and then they 
target the region of interest to introduce the mutation. The delivery system and its selective 
genes are never incorporated into the genome as with the older technologies. In addition, 
unintended modifications, similar to those occurring in natural systems may occur. 
Examples of unintended modifications, include:
•	  Mutations introduced at off-target genomic locations sharing homologous sequences 
with the target site.
•	 Potential expression of aberrant proteins for some types of knock-out mutations.
3.3 Genome editing: oligonucleotide-Directed Mutation (oDM) 
ODM is a site-specific gene modification system based on synthetic oligonucleotides (single 
stranded DNA molecules) homologous to the target genomic sequence, except for a small 
mutation. When these are introduced into a cell they can modify the target sequence after 
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homologous recombination and integration via the endogenous DNA repair mechanisms 
(Lloyd et al., 2005).
figure 3.4 A diagram illustrating the oligonucleotide-directed mutagenesis process (http://www.brc.hu) 
Key MeSSAGe
Genome editing techniques offer a unique set of advantages over conventional and GM 
crop breeding techniques in terms of accuracy, flexibility and relative simplicity, low costs 
and efficiency.
3.4 null (negative) Segregants
Null, or negative, segregants refer to the non-GMO offspring in a breeding programme where 
GM elements or traits were used transiently. For example, parents with GM traits that improve 
the efficiency of the selection and breeding process itself are used, but then these GM traits 
are segregated in the subsequent progeny and excluded from the selected lines.
3.4.1 Reverse Breeding 
Until recently it was not possible to exactly reproduce a heterozygous plant via seeds. 
Reverse breeding, however, is a recently developed breeding technique designed to do so 
through the ‘reverse’ production of homologous parental lines from a superior heterozygous 
plant. Subsequent hybridisation of selected complementary homozygous parental lines will 
reconstitute the original superior heterozygous line in seeds (Wijnker et al., 2012). 
Reverse breeding depends on the use of a genetic modification step that suppresses meiotic 
recombination, followed by a tissue culture step to create a range of homozygous (doubled 
haploid) parent lines. Complementary pairs of these newly developed parental lines are then 
used to stably produce the heterozygous elite plants through seed/hybrid breeding (Fig. 3.5).
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figure 3.5 Schematic overview of the final outcomes of different breeding approaches. During con-
ventional breeding, recombination in chromosome pairs results in the reshuffling of genetic mate-
rial, which results in the loss of the original, unique combination of genetic characteristics. Reverse 
breeding starts with a selected heterozygous individual in which meiotic recombination is suppressed 
through RNA interference (GM). A full set of doubled haploid parental lines are generated from this 
plant each with a different set of homozygous chromosome pairs. For hybrid variety production, pa-
rental lines in which the genetic variation of the chromosome pairs complement each other, e.g. in-
bred parent A and B above, are selected and crossed to yield uniform offspring hybrid plants (seeds), 
which are genetically similar to the plants with which the reverse breeding was started (Modified from 
http://european-seed.com)
Reverse breeding holds great potential for introducing hybrid vigour/heterozygosity into crop 
breeding programmes and can do so without prior knowledge of the genetic constitution of 
the crop. It further allows for precision breeding, i.e. manipulating individual chromosomes, 
and the quick identification of QTLs. Although the generation of the homozygous parental lines 
is dependent on a GM trait, this can be segregated in subsequently out crossings, rendering 
the final lines non-GMO. Finally, reverse breeding is currently limited to crops with a haploid 
chromosome number of ≤12 and where doubled haploid technology is routinely practised. 
3.4.2 Accelerated Breeding 
Accelerated breeding techniques involve the intermediate generation of GM organisms that 
contain a transgene to shorten the juvenile phase of the organism, thereby speeding up 
the breeding process, for instance in trees (Comeau et al., 2001). As with reverse breeding, 
the transgene is removed later by out crossing and segregation. In such a case no foreign 
genetic material is present in the final product.
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3.4.3 RNA-dependent DNA Methylation (RdDM) 
RdDM relies on the plants’ innate defence systems, specifically the RNA-induced silencing 
complex, which is activated by small double-stranded RNA molecules. The technique enables 
the release of varieties that have inherited an epigenetic modification, but not the inducing 
transgene itself. Many cellular processes, including gene expression and DNA replication, 
are controlled by elements such as promoters, enhancers, or binding sites for repressor 
proteins that are present or absent in the DNA sequence. Epigenetic modification in contrast 
involves the chemical modification of DNA without altering the genetic code itself and the 
proteins associated with DNA, which may result in changes to the conformation of DNA and 
accessibility of other factors to DNA, without a change to the primary sequence of the DNA.
Common types of epigenetic regulation are DNA methylation and hydroxymethylation, 
histone modification, chromatin remodelling, and regulation by small and large non-coding 
RNAs (Wu et al., 2010). As more factors influencing heredity are discovered, epigenetics is 
being used to decipher the roles of DNA, RNA, proteins, and environment in inheritance.
3.4.4 Possible Risks Associated with Null Segregants 
As with conventional breeding, the products of all these techniques will require thorough 
phenotypic assessments to confirm their characteristics. With regards to the transient GM 
trait(s) a thorough characterisation of the final products is needed to exclude the unexpected 
presence of GM sequences and/or traits. As a result of these initial modifications the breeding 
products may also exhibit phenotypes transmitted as inheritable epigenetic traits. The final 
breeding products should therefore be assessed for traits associated with the initial GM, e.g. 
meiotic aberrations or early flowering. Epigenetic modifications may be unstable and revert 
after a few generations.
3.5 Variants of Genetic Modification 
3.5.1 Cisgenesis and Intragenesis
In molecular biology, “cis” in general refers to “acting from the same molecule”. A cisgene 
therefore refers to an intact, functional gene sequence that occurs naturally in the target 
organism itself or a sexually compatible species, including its natural regulatory cis-sequences 
such as its promoter and terminator (Figs. 3.6 and 3.7). Therefore, the gene belongs to the 
conventional breeder’s gene pool and is the already existing result of natural evolution. In 
theory, the gene of interest could also have been moved from one species to the other using 
traditional breeding with the same result.
An intragene is a functional gene sequence that consists of functional elements, i.e. coding 
region, promoter and terminator, originating from different genes from the target organism 
itself or sexually compatible species. Therefore, all gene elements belong to the traditional 
breeders’ gene pool but in contrast to cisgenesis, an intragene is an artificial genetic construct 
(Fig. 3.7).
In contrast, transgenes consist of functional elements from sexually incompatible species, 
which have been transferred to a host organism using genetic engineering techniques – i.e. 
transgenesis (Figs. 3.6 and 3.7). 
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figure 3.6 Five techniques commonly used to generate new plant varieties - conventional plant breed-
ing, mutation breeding, targeted mutagenesis, transgenesis and cisgenesis (Reproduced with the per-
mission of Science & Society)
figure 3.7 Differences between transgenic, cisgenic and intragenic breeding (Reproduced with the 
permission of Science & Society)
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3.5.2 Transgrafting
Grafting has been used by plant growers for thousands of years to control growth and 
flowering in trees and some herbaceous plants by attaching a scion onto a suitable rootstock. 
In some cases, it may be beneficial to graft a non-GMO scion onto a GM rootstock (Fig. 3.8) 
or vice versa – called transgrafting.
figure 3.8 A diagram illustrating the two components of a graft – the non-GM scion and the GM root-
stock (http://germination.ca)
This may, for example, be beneficial where a GM rootstock can convey beneficial 
characteristics, such as more efficient nutrient uptake from the soil, better rooting ability 
and/or resistance to soil-borne diseases. In such cases, the non-GMO scion and its harvest, 
e.g. flowers or fruit, remain free of transgenic DNA. 
3.5.3 Possible risks associated with GM variants
The European Food Safety Authority  (EFSA) Panel on GMOs compared the hazards associated 
with cisgenic, intragenic and conventionally bred plants and concluded that the possible 
hazards associated with these plants are similar to the ones associated with conventionally 
bred plants (EFSA, 2012). The Austrian Environment Agency came to a similar conclusion in a 
recent review of the risks associated with NBTs (Eckerstorfer et al., 2014).
In transgrafting there is a chance that mRNAs, proteins and other mobile molecules could 
move along the phloem long distance translocation system (See Song et al., 2015 for a 
review). Horizontal gene transfer between the rootstock and the scion is also theoretically 
possible via this mechanism (Liu et al., 2010), but this has not actually been recorded, except 
in the graft union itself (Anon, 2013; Song et al., 2015).
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TrAnSIenT exPreSSIon SySTeMS
In transient expression systems, somatic tissues or cells, e.g. plant leaves or animal cell 
cultures, are transformed with functional, heterologous gene sequences that are transiently 
expressed while remaining episomal, i.e. they do not integrate into the host genome. 
Transformation of the tissue can be done using Agrobacterium, a number of direct transfer 
techniques, such as particle bombardment or injection, or fit-for-purpose virus expression 
vectors. Several vectors have been designed on the basis of DNA and RNA-based plant 
virus genomes and these vectors are used as single or multicomponent expression systems 
in different combinations depending on the protein of interest.
The advantages that transient plant expression systems offer include speed, adaptability, 
scalability, relatively low production costs, high yields and low risk of mammalian pathogen 
contamination, which has led to predictions that transient plant expression systems could 
offer a major advance in the production of pharmaceutical proteins. The production of 
different recombinant proteins in transient systems compared with established standards 
has been described by Komarova et al. (2010) and Pogue et al. (2010) 
Although transgene sequences are used in these systems they do not integrate with the host 
genome and, besides, the host tissues/cells are sacrificed after a few hours to extract the 
recombinant protein product. No GMOs are therefore produced during the production/
expression cycle. However, a GMO may be used for transformation, e.g. Agrobacterium, 
which will yield a GMO/non-GMO tissue mixture that may be subject to GMO regulation. 
The regulation of these systems will therefore have to be decided on a case-by-case basis, 
but because they fall outside the scope of this study they will not be discussed further here. 
3.6 research, Development and Application Status of nBTs
The techniques discussed above have sparked huge interest for application in bio-innovation. 
Not only do these techniques, and in particular CRISPR, promise to make genomic modifications 
more accurate and simple, but also do so quickly, efficiently and cost-effectively. For example, 
the number of publications and patents involving CRISPR has increased one hundred-fold 
over the past five years, while funding by the NIH increased ten-fold in only one year – 2013 
to 2014 (Ledford, 2015). 
Although much of the above-mentioned interest focuses on health and medicine innovation, 
the utility of these techniques in breeding programmes, which is the focus of this study, is clear. 
In fact, products bred using these techniques have already received commercial approval 
in certain territories. Moreover, non-browning mushrooms, high-amylopectin maize and 
herbicide-tolerant oilseed rape are just some of the genome edited products which were 
found to be exempt from GMO regulations in the USA and therefore free to enter the market 
(Anon, 2015; Gill, 2016). Other products close to market include herbicide-tolerant maize, 
fungal-resistant potatoes, drought-tolerant maize, scab-resistant apples and potatoes with 
reduced amylose content. Many of these products have been developed by small research 
and development laboratories in the public and academic sector or by small enterprises – 
underlining the accessibility, utility and value of these techniques.
SDNs have been used to improve the nutritional quality maize and canola, produce higher 
yield tomatoes, diseases resistant wheat, bacterial blight-resistant rice, nematode-resistant 
soybean and in cell biology research in a multitude of organisms ranging from fruit flies and 
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nematodes to zebrafish and cattle. ODM was used in the development of herbicide-tolerant 
oilseed rape, rice and flax. Cis and intragenesis have been used to developed products 
such as fungal-resistant papaya, improved forage ryegrass, scab-resistant apple, bacterial 
blight-resistant potato and rice, drought and cold-tolerant maize and a variety of improved 
vegetable crops, while transgrafting is used in fruit trees to combat diseases such as citrus 
greening and plum pox virus.
3.7 Conclusion
NBTs are emerging rapidly from advances in genomic research and are already being 
applied in crop improvement. These NBTs enable precise, targeted and reliable changes in 
the genome, distinguishing them from first generation GM technologies, and have significant 
potential for the sustainable intensification of agriculture and ensuring food security. Unlike 
chemical or radiation-induced mutagenesis, often traditionally used as a basis for crop 
improvement, the NBTs do not create multiple, unknown, unintended mutations throughout 
the genome.
For several of the techniques, the resultant plant products are free from exogenous gene 
sequences and are therefore indistinguishable from potential products generated by 
conventional breeding techniques. This necessitates greater clarity regarding the definition of 
GM and the evolution of regulatory approaches and frameworks.
Key MeSSAGeS
•	  When using some NBTs, it will be impossible to tell what method was used to produce a 
new crop variety, because exactly the same DNA changes could be introduced using a 
variety of conventional breeding techniques. The boundaries between established GM 
and non-GM techniques will become increasingly blurred as techniques develop.
•	  It is important for policymakers to recognise that the NBTs are already widely used in 
research and development, and that commercial applications are likely to follow very 
soon. Regulatory processes therefore need to be able to accommodate them as a mat-
ter of urgency.
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ChapTer 4
The Current regulatory 
framework for gmos
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4.1 Introduction
NBTs are a wide and evolving range of interventions aimed at modifying genomes and/or 
gene expression to impact the phenotype of the resulting organism in a specific manner 
– some resembling GM technology to some extent. However, the varied nature of these 
techniques and their possible outcomes prevent their clear-cut categorisation in terms of 
GM technology alone. A prudent overview of the current regulatory framework for GMOs is 
therefore required to establish its scope and possible overlaps and/or differences in relation 
to the various NBTs. Such an analysis would also indicate if the current regulatory framework 
can be used to regulate, not only the current NBTs and their products, but also possible future 
breeding technologies (a concept that is further developed in Chapter 6). 
4.2 The South Africa regulatory framework for GMos
SAGENE  was South Africa’s first regulatory body for GMOs. Established in 1979, as a result of 
the initiative of the local scientific community, its members undertook laboratory inspections 
and provided guidelines for the assessment and evaluation of GMOs. In 1989, SAGENE 
advised the National Department of Agriculture on the field testing of Bt cotton, which 
was approved in terms of the Agricultural Pests Act (Act 36 of 1983). In 1992, SAGENE was 
given the remit to advise on legislation and/or controls on the importation and/or release 
of “organisms with recombinant DNA” and in January 1994, this was broadened to GMOs, 
defined in similar terms as used later in the GMO Act. SAGENE continued to act in this 
capacity until the GMO Act (Act 15 of 1997) came into effect on 1 December 1999. 
Currently, South Africa regulates the development and use of GMOs primarily in terms of the 
GMO Act and the GMO Amendment Act (Act 23 of 2006). The aim of the GMO Act is to pro-
mote the responsible development, production, use and application of GMOs and further 
establishes the necessary operational procedures and infrastructure required for the regula-
tion of GMOs, including:
•	  The Registrar (seated within the Department of Agriculture, Forestry & Fisheries (DAFF)), 
responsible for administering the Act.
•	 Inspectors, responsible for ensuring adherence to permit conditions.
•	  The Advisory Committee (AC), a panel of independent scientists that evaluates all appli-
cations.
•	  The Executive Council (EC), the decision-making body that consists of ten members repre-
senting seven different state agencies, i.e. DAFF, Department of Health (DoH), DST, Depart-
ment of Environmental Affairs (DEA), Department of Trade & Industry (the dti), Department 
of Labour (DoL) and Department of Arts & Culture (DAC).
In addition, the Regulations to the GMO Act establish: 
•	  the appropriate administrative and decision-making procedures for permit applications 
for activities involving the use of GMOs;
•	  common measures and minimum requirements for the risk assessment and management 
of the potential risks associated with GMOs;
•	 minimum risk communication and public participation requirements;
•	  the appropriate linkages with other relevant national and international GMO regulations;
•	 provisions regarding appeals and penalties.
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GMos In SouTH AfICA
Cotton was the first GM crop tested in South Africa in 1990. Approval for the commercial 
release of this crop was granted in 1997. Once full assessments had been carried out, adoption 
was very rapid and the present national cotton crop is 100% GM. GM maize was approved for 
commercial release in 1998 and the first application comprised some six yellow maize hybrids. 
In 2015, 90% of the 2 million ha of maize was GM. GM soybeans were approved in 2000 and 
about 5% of the 2001/2002 crops was GM. In 2015, 95% of the national soybean crop was GM 
(James, 2015).
South Africa’s experience of the first 20 years of commercialisation of GM cotton, maize and 
soybean, 1997 to 2016, has confirmed the benefits of crop biotechnology GM crops, which 
have delivered substantial agronomic, environmental, economic, health and social benefits 
to farmers and, increasingly, to society at large.
To date, all the GMO products approved for general release in South Africa have been 
developed outside the Republic by large multi-national companies, which raises questions 
regarding the impact of complex and costly regulatory requirements on local innovation.
In the GMO Act a “genetically modified organism” is defined as “an organism the genes or 
genetic material of which has been modified in a way that does not occur naturally through 
mating or natural recombination or both, and ‘genetic modification’ has a corresponding 
meaning”. 
The GMO Act does not apply to techniques:
(a) involving human gene therapy; 
(b)  in which recombinant DNA molecules or genetically modified organisms are employed 
1 in in vitro fertilisation in humans and animals;
2 in conjugation, transduction, transformation or any other natural process; 
3  in polyploidy induction;
(c)  in which genetically modified organisms as recipient or parental organisms are not 
employed
(i) in mutagenesis;
(ii) in the construction and use of somatic hybridoma cells;  
(iii) in cell fusion (including protoplast fusion) of plant cells.
However, the Act does not define:
•	  Genetic recombination – the transmission genetic process by which the combinations of 
alleles observed at different loci in parental individuals become shuffled in offspring indi-
viduals.
•	  Mutagenesis – a process by which the genetic information of an organism is changed in a 
stable manner, resulting in a mutation.
•	  Mutation – a change in the structure of genetic material, resulting in a variant form that 
may be transmitted to subsequent generations, caused by the alteration of single-base 
units in DNA, or the deletion, insertion, or rearrangement of larger sections of genes or 
chromosomes.
•	 Naturally – happening or existing as part of nature. 
•	 Novel – cannot conceivably occur naturally.
The current general consensus is that the South African regulators have principally adopted 
a process-based approach to GMO regulation (as opposed to a product-based one), 
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based on the perception that the definition of a GMO in the Act, and therefore the trigger 
for regulation, hinges on how the organism was created, i.e. “…which has been modified in 
a way that does not occur naturally…”, and not purely on its risk characteristics. However, 
the EC of the GMO Act’s decision to also regulate breeding stacks of approved GMO lines, 
contradicts the above as it is clearly a product-based trigger. In practice, South African GMO 
regulators have therefore apparently taken an ad hoc approach, which may include both 
process and product-based triggers for GMO regulation. However, it can be argued that the 
relatively limited range of GMOs that have been evaluated to date has not really tested this 
supposition.
In addition to the GMO Act several other pieces of legislation make direct reference to the 
regulation of GMOs, including:
•	  Food labelling regulations under the Foodstuffs, Cosmetics and Disinfectants Act (Act 54 
of 1972).
•	  Environmental impact and monitoring regulations under the National Environmental Man-
agement Biodiversity Act (Act 10 of 2004).
•	 Food labelling regulations under the Consumer Protection Act (Act 68 of 2008).
Key MeSSAGe
South Africa has a well-established, representative and robust regulatory framework for 
GMOs and a successful track record in science-based risk assessment, commercialisation 
and post-release management of GMOs.
4.3  The Cartagena Protocol on Biosafety (CPB)
The CPB is a legally binding global protocol that seeks to contribute to ensuring the safe 
transfer, handling and use of living modified organisms (LMOs) created through modern 
biotechnology. Currently 170 countries, including South Africa, are party to Protocol, which 
ratified it in 2003. 
Article 1 of the Protocol states that it aims to “contribute to ensuring an adequate level of 
protection in the field of the safe transfer, handling and use of living modified organisms 
resulting from modern biotechnology that may have adverse effects on the conservation and 
sustainable use of biological diversity, taking into account risks to human health as well, and 
specifically focusing on transboundary movements”. In short, it seeks to protect biodiversity 
from the potential risks of LMOs resulting from modern biotechnology.
The CPB defines a GMO, specifically called an LMO in the Protocol because it only applies 
to living modified organisms, as “any living organism that possesses a novel combination of 
genetic material obtained through the use of modern biotechnology”.
While modern biotechnology is defined as any application of:
•	  in vitro nucleic acid techniques, including recombinant DNA and direct injection of nu-
cleic acid into cells or organelles, or
•	  fusion of cells beyond the taxonomic family, that overcome natural physiological repro-
ductive or recombination barriers and that are not techniques used in traditional breeding 
and selection.
If emphasis is placed on the second part of the definition for LMOs, i.e. “the use of modern 
biotechnology” it may suggest a process-based approach to regulation under the Protocol. 
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However, “a novel combination of genetic material” is not clearly defined, which leaves the 
exact meaning of the definition, and therefore the scope of the Protocol, open to interpretation. 
This fact was also highlighted in the deliberations of the Argentinian regulatory authorities 
when they considered the regulation of NBTs under the Protocol (Whelan and Lema, 2015). 
In addition, the term “novel combination of genetic material” is always used, with only one 
exception, in combination with the word “detectable” in the Protocol’s text, i.e. “detectable 
novel combination of genetic material”, which could have an impact when considering the 
Protocol’s mandate over the wide and variable range of possible NBT products.
 
The Protocol covers the “transboundary movement, transit, handling and use of all living 
modified organisms that may have adverse effects on the conservation and sustainable use 
of biological diversity, taking into account risks to human health”. It requires that decisions be 
based on risk assessments that are undertaken in a scientific manner based on recognised risk 
assessment techniques, taking into account advice and guidelines developed by relevant 
international organisations. In this regard, a lack of scientific knowledge or scientific consen-
sus should not necessarily be interpreted as indicating a particular level or risk, an absence or 
risk, or an acceptable risk. Risks associated with LMOs or their products should be considered 
in the context of risks posed by the non-modified recipients or parental organisms in the likely 
potential receiving environment. Risk assessment should be carried out on a case by case 
basis.
4.4 Conclusion
In South Africa, GMOs are primarily regulated in terms of the GMO Act (Act 15 of 1997) and 
its amendments and the country has 20 years of experience in the development, use and 
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regulation of GMOs. The definition of a GMO in the Act hinges on its “unnatural” character 
and stands central to defining the Act’s mandate, but there is currently no clear consensus 
on whether it purports a process or product-based trigger and its possible knock-on effects. 
Clarifying this issue will allow for the accurate classification of the products of all current and 
possible future biotechnologies, including NBTs, and establish the GMO Act as the principle 
regulatory instrument for those products that do require regulatory oversight. 
The CPB is the legally binding international Protocol that seeks to protect biodiversity from 
the potential risks of LMOs, in contrast to possible non-living products from GMOs, resulting 
from modern biotechnology. It promotes biosafety by establishing rules and procedures 
for the safe transfer, handling and use of LMOs and facilitates information and experience 
sharing, including, procedures for moving LMOs across borders, risk assessment practices, an 
international biosafety clearing house, capacity building and public awareness programmes.
In South Africa, the development and use of GMOs are subject to both national and inter-
national regulatory frameworks. However, the frameworks’ definitions of GMOs and in other 
words, that which is subject to regulation, are not well-aligned. The advent of the NBTs has 
further exposed ambiguities within the various legal definitions of GMOs that are used around 
the world. When considering the possible regulation of NBTs and/or their products using cur-
rent GMO frameworks, it will therefore be critically important to first define, within a context 
of risk management, exactly what constitutes a GMO or regulated entity to minimise possible 
international misalignment – a concept that is further developed in Chapter 6. 
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ChapTer 5
Current global approaches 
to the regulation of nbTs
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5.1 Introduction
To date very few countries have developed official policies to determine the regulatory 
status of products derived from NBTs, and where such instruments do occur, they are not very 
useful as a model because of the differences in legal frameworks and definitions between 
countries. Argentina is currently the only country where the regulators have made a formal 
pronouncement on the regulation of NBTs. Most countries are still debating the issue internally 
and have not yet reached a conclusion. The approaches used in various countries are 
considered below.
5.2 Argentina
Argentina based its regulatory system on the CPB definitions and as a result, the country’s 
legislation is fully compatible with the Protocol (Whelan and Lema, 2015). Argentina concluded 
that the “novel combination of genetic material” should be the key trigger when deciding if a 
product derived from a NBT is to be considered a GMO or not. In this regard, therefore:
•	  Products derived from cisgenesis, intragenesis, SDN-3 and synthetic biology are considered 
to be GM.
•	  Grafting between GM and non-GM plants – the whole plant is regarded as GM, regardless 
of whether the GM part is the rootstock or scion.
•	  SDN-1, SDN-2 and reverse breeding – if the applicant can show evidence of the removal 
of the SDN or transgenic material from the final product the product would be considered 
a non-GM otherwise it is still a GMO.
•	  Epigenetic modifications such as RdDM are not considered a new combination of genetic 
material but in some cases the DNA insertions would have to be removed. However, be-
cause these modifications are often unstable and revert after a few generations they may 
have little commercial interest in practice.
•	  ODM – depending on the nature and extent of the modification, products derived from 
these techniques could be considered non-GM.
•	  Agro-infiltration – these techniques are unlikely to serve a practical purpose for commer-
cial agriculture but may be of value in molecular pharming. The focus of any regulation 
should be on the GM micro-organism.
Notwithstanding the above conclusions, the Argentine regulators emphasise the principle 
of a ‘case-by-case’ approach, which affords the regulator the opportunity to make a final 
decision only once the details of any particular application have been considered. This also 
allows for the handling of any possible future derivatives or new techniques that may evolve.
5.3 Australia and new Zealand
While New Zealand is a party to the CPB Australia is not, but both countries have definitions 
and regulations that cover the regulation of GMOs.
Current Australian GMO legislation requires the determination of whether a NBT is covered by 
the GM regulations to be made on a case-by-case basis. In 2012 and 2013, Food Standards 
Australia/New Zealand convened an expert scientific panel to provide advice on how to 
regulate different NBTs. The panel grouped NBTs into three categories:
 1  Cisgenesis, intragenesis, SDN-3 and GM rootstock grafting – any products derived from 
these NBTs should be regarded as GM.
2  ODM and SDN-1 – any products derived from these NBTs should not be regarded as GM.
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 3  Reverse breeding – products derived from this NBT are not GM but the reliability of the 
breeding process needs to be confirmed.
In a recent statement, the Agricultural Biotechnology Council of Australia (ABCA, 2016) 
recognised the importance of new techniques in plant and animal breeding. In most cases, 
NBTs are innovative improvements and refinements of traditional plant and animal breeding 
methods. Breeders can now induce very specific changes in plant and animal genes in a way 
that mimics the changes that occur in nature or through traditional breeding methods. The 
use of NBTs can enable breeders to create the same, desired genetic variation with greater 
precision and efficiency than previous breeding methods. Genomic changes produced by 
NBTs should be viewed in light of the inherent natural variability of plant and animal genomes, 
the comparable genomic changes that occur with the use of traditional breeding methods, 
and the long safe history of the use of traditional breeding methods. ABCA added that 
regulatory oversight of products developed through NBTs, if needed, should be based on 
sound scientific principles and should be proportional to risk. Regulatory oversight that is not 
proportional to risk is not value adding and results in delays and higher costs, which limit the 
access of small and medium sized enterprises (SMEs) and public breeding institutions to the 
latest innovative breeding tools. ABCA stated that plant and animal breeders need regulatory 
certainty so they can reliably plan their breeding programmes, product development and 
market strategies. Consistent regulatory oversight of products developed using NBTs would 
facilitate innovation and allow the uptake of advanced, innovative breeding applications by 
both private and public sector breeders.
In October 2016, Australia’s Office of the Gene Technology Regulator (OGTR) published 
a discussion paper on Opinions for Regulating New Technologies in which they requested 
public inputs on the proposed regulation of NBTs. They listed four possible options on how 
to approach NBT regulation; viz. (1) no amendment to the current GMO legislation, (2) 
regulate selected techniques, (3) regulate some selected techniques based on the process 
used and (4) exclude certain selected techniques based on the products they produce. The 
advantages and disadvantages of the respective approaches they listed could add value to 
the South African discussion and are therefore presented in Table 5.1.
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5.4  Canada
Canada’s Biotechnology Regulatory Framework is product-based and is concerned with 
plants containing a trait not present in the same species already existing in Canada. There-
fore, since Canada’s regulatory system applies to novel products irrespective of breeding 
technique, it is not expected to require any amendment to accommodate case-by-case 
decisions on products derived from NBTs.
5.5  uSA
Under the US Plant Protection Act (Public Law 106 – 224, Section 401, 20 June 2000), the USDA 
determines the regulatory status of products derived from NBTs based on a case-by-case 
analysis, but neither the EPA nor the FDA has specifically declared a policy approach on NBT 
products. Several products have already been identified by the USDA to not fall under the 
regulation usually applied to GMOs. 
For example, in 2015, researchers at Pennsylvania State University developed a transgene 
free, anti-browning white button mushroom using the CRISPR-Cas9 technique to produce 
several small deletions in a specific polyphenol oxidase gene. These deletions disabled the 
enzyme polyphenol oxidase, which causes browning in some fruits when they are exposed to 
air, but otherwise lacks any major role in plant metabolism. The innovators responsible for this 
solution to the problem of food waste decided to consult the USDA before moving further to-
wards commercialisation. They wanted to know whether their product would be considered 
a GMO, or be exempted from such due to the lack of any demonstrated potential for hazard, 
as are all varieties derived from ‘conventional’ breeding. After studying their application, Ani-
mal and Plant Health Inspection Service (APHIS) concluded that the anti-browning mushroom 
fell outside the scope of the regulations under which APHIS acts to prevent or manage risks to 
US. agriculture. However, it was still subject to FDA regulations which require all food placed 
on the market to be safe.
The US regulatory criteria for biotechnology are based on its very particular legal framework; 
a determination of regulated/non-regulated status can therefore not be readily transplanted 
to most other countries which base their regulation on language similar to that of the CPB. The 
USA has announced that it intends to carry out a major update of the regulatory system which 
will take into account the future development of biotechnology techniques and products.
5.6  united Kingdom
The United Kingdom’s (UK) Advisory Committee on Releases to the Environment (ACRE) was 
requested to provide information on NBTs, the organisms they generate and arguments for 
and against their regulation under the GMO legislation (ACRE 2013a, 2013b, 2013c). This 
information was published in 2015 and Table 5.2 summarises the status of the techniques and 
the organisms generated by them. Note that a combination of these techniques may be 
used in the generation of a new plant variety.
Many of these techniques are not only used in the genetic modification of plants but also of 
animals and micro-organisms.
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Table 5.2 A summary of the status of certain NBTs as compiled by UK Advisory Committee on Releases 
to the Environment (ACRE )
Technique Involves a GM technique?
Produces an intermedi-
ate product that is a 
GMo?
offspring are GMos?
Cisgenesis/intragenesis Yes - Yes
Reverse breeding Yes Yes No
Agro-infiltration Yes Questionable No
Grafting (non-GM 
scion/GM rootstock) 
No Yes No
RNA-dependent DNA 
methylation 
No – nucleic acid 
molecules not in-
serted into genome
No No
Yes – nucleic acid 
molecules inserted 
into genome
Yes No
Oligo-directed mu-
tagenesis 
Yes No No
Zinc-finger nucleases 
(mutagenesis) 
Yes No No
ACRE highlighted the following three issues requiring legal clarification:
•	  Are the offspring of GMOs necessarily GMOs? The answer could affect the status of organ-
isms produced by reverse breeding. 
•	  It is not clear what “altering the genetic material of an organism in a way that does not 
occur naturally by mating or natural recombination” means. Does it require the formation 
of new combinations of genetic material that do not occur naturally? In which case, it 
would not include modifications that do not alter the nucleotide sequence of the genetic 
material, or changes that will result in nucleotide sequences that are likely to be present 
in nature or as a result of conventional breeding. This question has ramifications for other 
issues linked to interpreting the definition. In particular, the answer could affect the status 
of cisgenics and RNA-dependent DNA methylation. 
•	  The relevance of referring to “recombinant nucleic acid molecules” where these mole-
cules are not inserted into the genome of the host organism. This point has a bearing on 
the status of organisms produced by mutation, such as through the use of zinc-finger nu-
cleases or oligonucleotides.
5.7 Germany
The position of the German Biosafety Commission (Anon, 2012), on whether the offspring of 
several NBTs should be considered GMO or not, is shown in Table 5.3.
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Table 5.3 The status of certain NBTs as per the 2012 position statement of the German Biosafety Com-
mission
Technique Are offspring GMos?
Cisgenesis 
– border sequences and/or marker genes are present
– no border sequences present and marker genes removed
Yes
No
Intragenesis Yes
Reverse breeding 
– Step 1: trans DNA in parent organism
– Step 2: double haploid production
– Step 3: reverse bred organism with no trans DNA
Yes
No
No
Agro-infiltration (not GM itself, but contains a GMO)
Agroinoculation/Agroinfection
Floral Dipping
NA
No
Yes
Grafting 
– reproductive offspring from non-GM part
– reproductive offspring from GM part
No
Yes
RNA-directed DNA methylation
– for stably integrated recombinant DNA in the genome of the recipient organism 
– for transient recombinant DNA
– when introducing isolate RNA
Yes
No
No
Oligo-directed mutagenesis No
Zinc-finger nucleases
ZFN1 
ZFN 2
ZFN 3
No
No
Yes
5.8 Sweden
The Swedish Board of Agriculture was one of the first competent authorities that pronounced 
on the possible regulation of some types of genome edits, when they concluded in Novem-
ber 2015 that type 1 and 2 CRISPR-Cas9 edits, which may also occur naturally, do not fall 
under the European GMO definition. 
5.9 Switzerland
In 2016, the Swiss Academies of Arts and Sciences concluded that the genetic makeup of 
plants can be modified precisely by means of new breeding techniques. Typically, these 
changes could also occur naturally and, in the process, no genetic material that is unrelated 
to the species remains in the plant. These techniques significantly broaden the possibilities 
for plant breeding, thereby potentially helping to make agriculture more environmentally 
friendly, economically viable and ultimately more sustainable. As some varieties developed 
by using the NBTs already exist and new ones are expected to follow shortly, it is imperative to 
determine whether or not plants engineered by means of these new techniques are subject 
to the Gene Technology Act. From a natural scientific point of view, the Swiss Academies 
found that there is no reason for a strict regulation of plants bred in this fashion.
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5.10  european union (eu)
After inquiries from the academic sector as well as the biotechnology industry regarding the 
regulatory status of plants obtained by NBTs, an ad hoc working group was established by the 
European Commission. The working group finalised its report in 2012 but this report has not yet 
been released. 
In 2012 the Joint Research Centre of the EU published safety assessment criteria on cisgenesis, 
intragenesis and ZFN 3, which are considered to be the NBTs with the best chance of their 
derived products being universally classified as GMOs.
5.11 oeCD
The OECD has a permanent Working Group on Harmonisation of Regulatory Oversight in Bio-
technology which is addressing NBTs as an emerging issue. In a report published in 2015, it was 
noted that in most member countries the development of NBTs is still at the research phase. 
National authorities are only now beginning to consider if and how NBT-derived products are 
to be regulated.
5.12 other 
Schaart and Visser (2009) described four classes of NBTs and indicated which plants or prod-
ucts produced by each should be considered as GMOs (Table 5.4).
Table 5.4 Novel plant breeding techniques, consequences of new genetic modification-based plant 
breeding techniques
Class Description nBTs GMO/Non-GMO
1 Plants and products do not contain any 
genetic material that was used for the ini-
tial genetic modification, therefore, plants 
and products are similar to traditionally 
bred plants. Consequently, the environ-
ment and food and feed safety do not 
differ from that of traditionally bred plants. 
Proof should be requested that the plants 
or product are Agrobacterium-free, virus- 
free and transgene-free using accepted 
standard techniques and/or methods.
Agro-infiltration
Virus Induced Gene 
Silencing
Reverse Breeding Ac-
celerated Flowering
Non-GMO
Non-GMO
Non-GMO
Non-GMO
2 Although products from the non-genet-
ically modified part of the grafted plant 
do not contain any genetic material that 
was used for the initial genetic modifica-
tion, RNA molecules, proteins and me-
tabolites that are related to the genetic 
modification may be present. Proof should 
be requested that the plants or product 
are Agrobacterium-free, virus-free and 
transgene-free using accepted standard 
techniques and/or methods.
Grafting Non-GM scion = 
Non GMO
GM scion = 
GMO
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3 Plants contain DNA sequences that have 
been introduced by genetic modification. 
The introduced genes originate from the 
species itself or from a cross-compatible 
species. If the introduced genes show an 
expression that corresponds to the base-
line, such cisgenic and intragenic plants 
are regarded as similar to the baseline, 
also in terms of environmental safety and 
food and feed safety. If it is also proven 
that the final product is free of agrobac-
teria and sequences that are foreign to 
the species, such cisgenic and intragenic 
plants are not considered to be GMOs. In 
general, however, intragenesis is aimed 
at differential expression of genes. If for 
intragenesis an alternative promoter 
was used to alter the expression of an 
intragene, the intragene expression may 
deviate from that of the baseline. In such 
a case, additional studies are required to 
assess the environmental and food and 
feed safety.
Cisgenesis
Intragenesis
Non-GMO
GMO
4 Plants and products do not contain any 
genetic material that was used for the 
initial genetic modification. The genetic 
modification was used as a tool to in-
troduce specific mutations. Plants and 
products obtained through this class of 
plant breeding technique are similar to 
the plants obtained by traditional muta-
tion breeding, which are used as baseline 
references, and the consequences for the 
environment and food and feed safety do 
not differ from that of traditionally mutated 
plants.
ZFN 1
ZFN 2
ZFN 3
ODM
TALENs
CRISPR
Non-GMO
Non-GMO
GMO
Non-GMO
Non-GMO
Non-GMO
In a recent US survey of academic and industry-based experts in biotechnology and 
gene editing techniques, representatives of regulatory agencies overseeing biotech-
nology, non-government organisations (NGOs) and consumer groups concerned with 
the health and environmental effects of biotechnology, Kuzma et al. (2016) identified 
the following regarding the respondents’ concerns about targeted genetic modifica-
tion as compared to traditional biotechnology:
More problematic concerns less problematic concerns
•	 Communication and public understanding
•	  Greater public distrust due to negative experiences 
with GM
•	 Security issues may become more problematic
•	 Ethical oversight
•	 Fair distribution of benefits
•	  Fascination with gene editing may overshadow 
safety concerns
•	 Animal welfare concerns 
•	 Environmental safety
•	 Toxicity
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Similar concerns
•	 International harmonisation of regulation
•	 Fair distribution of benefits
•	 Public understanding and acceptance
•	 Regulatory capacity building in developing countries 
•	 Mmaintaining crop variety
•	 Ownership of germplasm banks
•	 Intellectual property rights (IPR)-related impact on competition
•	 IPR-related impact on public research
•	 Impact on access in developing countries
•	 Impact on research relevant to the needs of developing countries
They also anticipated that gene editing may initiate the following regulatory changes:
•	  Greater speed of development, adoption, production may overwhelm the regulatory sys-
tem.
•	 Faster approval processes.
•	  Greater variability in traits and products may not be successfully handled by the regulatory 
authorities.
•	 New definition of GM will be necessary.
•	  Greater access to technology will present issues for regulatory regimes and their coordina-
tion.
•	 Will fail the old process approach.
•	 Regulators will start to encourage the technique.
•	 New ethical concerns.
•	 New scientific capacity will be required from regulators.
•	 Less testing will be necessary.
Finally, respondents indicated their degree of concern regarding various aspects of gene 
edited plant products. This is summarised in Table 5.5.
Table 5.5 The degree of concern regarding various aspects of gene edited plant products among US 
stakeholders (from Kuzma et al. 2016)
Concern
Degree of concern*
1 2 3
Environmental risks 55.5% 33.3% 11.1%
Human health safety 66.6% 22.2% 11.1%
Intellectual property rights issues 37.0% 25.9% 37.0%
The ability of farmers to afford products 51.8% 25.9% 22.2%
The adequacy of public funding for basic research 40.7% 33.3% 25.9%
The adequacy of public funding for product development 48.1% 11.1% 40.7%
The adequacy of public funding for environmental and human 
health studies 29.6% 14.8% 55.5%
The control exerted by industry 37.0% 14.8% 48.1%
The technical performance of the products 61.5% 23.1% 15.4%
*1 – Somewhat or not at all; 2 – Moderately; 3 – Very to extremely
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5.13 Conclusion
The NBTs which have been developed since the introduction of GM legislation represent a 
clear challenge for regulators as their classification under current GMO legislation is not clear. 
Comparison of the situation in several countries and the remarks made by several other or-
ganisations show that: 
(i) legislation, definitions and regulatory approaches differ significantly,
(ii) very few competent authorities have to date finalised their approach to NBT regulation,
(iii) decisions are currently taken on a case-by-case basis,
(iv) there has been very little focus on international harmonisation. 
There also seems to be general consensus that:
(i)  current GMO systems and approaches are relevant and sufficient to also accommo-
date those NBT products that may be regulated; 
(ii)  due to the large possible differences between different NBT products and the fact that 
new techniques will continue to be developed, it is highly inadvisable to base the defini-
tion of a regulatory trigger on techniques or technologies; 
(iii)  not all NBTs should be subject to regulation (although defining a coherent, principle and 
widely acceptable regulatory threshold/trigger will probably prove to be difficult); 
(iv)  an effective and adaptive regulatory framework, able to handle all current and pos-
sible future ‘genome modification techniques’ requires a well-defined regulatory trig-
ger, based on risk management principles, and the ability to consider products on a 
case-by-case basis when necessary.
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ChapTer 6
regulatory frameworks 
and risk analysis for nbTs
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6.1 Introduction
The ongoing debate on the regulatory status of NBTs is complex because of the wide range 
of techniques deployed and their variable impact on the heritable traits of the target or-
ganism’s genome. In addition, definitions for biotechnology-derived organisms, and GMOs in 
particular, were developed in the late 1980s to early 1990s and are still being applied without 
up-dates in most countries. As a result, the recently developed NBTs cause uncertainty for 
both developers and regulators as it is unclear whether organisms, developed using these 
techniques, fall under current GMO legislation or not. 
A further complication is that the legislation, definitions and regulatory approaches for bio-
technology-derived organisms, differ significantly between countries. As a result, there are 
concerns that the introduction of these new techniques could lead to further non-harmo-
nised regulatory approaches and asynchronous development and marketing of such crops 
and animals, resulting in trade disruptions.
The two major questions that arise are:
(i) if and how NBTs should be integrated into current regulatory systems, 
(ii)  if the current risk analysis framework used for GMOs will be appropriate and sufficient to 
assess the potential risks that may be associated with these applications.
6.2 Proportionate regulation
The accuracy, relative simplicity and low cost of some NBTs places the power of precise ge-
netic engineering, and its huge potential gains, in the hands of a much wider spectrum of 
innovators, including those in the public sector, SMEs and those working with minor and or-
phan crops. However, the adoption of these technologies and reaping their benefits is highly 
dependent on the regulatory requirements for their resulting products. An under-appreciated 
impact of excessive regulation is that it disproportionately affects small enterprises and the 
public research environment, which lack the necessary appetite and resources to comply 
with burdensome and costly regulatory requirements (Conko et al. 2016). It is also well un-
derstood that regulatory approaches have the potential to influence the risk perceptions 
regarding these technologies and their products – potentially unduly raising public concern 
and negatively impacting the deployment of products produced through such technologies.
Unnecessary regulation and oversight of such products, based on the method of develop-
ment, would result in undue, costly regulatory burdens, stifle innovation and prevent the up-
take of scientifically advanced, innovative breeding applications by the public and private 
sectors. In addition, the regulatory status of NBTs will impact trade not only in plant propagat-
ing material but also in agricultural commodities derived from this material. Different gov-
ernment approaches risk disrupting international commodity trade flows, particularly in a 
scenario where various levels of regulation are applied to the same type of product, with 
asynchronous pre-market approvals.
Miller (2010) and Barton et al. (1997) presented the Stanford Model for regulation of field trials 
with GM plants, being unsatisfied with the lack of proportion between risk and regulatory 
scrutiny. This model stratifies organisms according to risk in field trials, and is analogous to 
existing regulatory regimes. The advantage of the Stanford Model is that it is sufficiently 
flexible to accommodate differences in regulatory authorities’ preferences for greater or 
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lesser regulatory stringency, as long as the risk factor of each category is coupled with an 
appropriate and relative regulatory requirement. Another similarly flexible model has been 
presented by Araki and Ishii (2015), setting up the continuum of genetic alterations in a range 
from minor (leaky or null mutations) to major (transgenesis) changes. Four levels of stringency 
in the regulation are imposed along this range, allowing policymakers to shift towards more 
permissive regulation for certain genetic alterations as evidence of safety accumulates. This 
model would also promote global harmonisation of regulatory frameworks. The benefit of 
this model is, that it has the flexibility to start off with a relatively process-directed system of 
regulation, that is politically acceptable to many stakeholders today while allowing a shift 
towards more product-based interpretations as scientific evidence accumulates and the 
products gain a safe history of use.
Key MeSSAGe
The regulation of any biotechnology and/or its products should only be considered when 
the risks they pose are significantly greater than those posed by comparable, natural 
biological systems and then it should be proportional to the risks it manages and balanced 
with the benefits the technology promises.
6.3 Product versus Process-based regulation
In 1987, the US National Research Council (NRC) concluded that the product of genetic 
modification and selection should be the primary focus for making decisions about the risks 
of environmental introduction of a plant or micro-organism, not the process by which the 
products were obtained (NRC, 1989). Their report concluded that evaluation of experimental 
field testing should be based on:
•	 knowledge about the traits of the organism and the test environment;
•	 the ability to confine or control the spread of the organism, as necessary; 
•	 the likelihood of harmful effects if the organism should escape control or confinement.
In 1992, the US National Biotechnology Policy Board concluded that the risks associated with 
biotechnology were not unique and tend to be associated with particular products and their 
applications, not with the production process or the technology per se. In fact, biotechnol-
ogy processes tend to reduce risks because they are more precise and predictable (National 
Biotechnology Policy Board, 1992).
In addition, any regulatory scheme should also incorporate the general principles that:
•	  the degree of regulatory scrutiny should be proportionate with the level of risk, keeping in 
mind the difference between real and perceived risk; 
•	 similar things should be regulated in a similar way; 
•	 the scope of what requires regulatory review must make sense. 
These principles have been the basis for all OECD regulatory guidance documents since 1995. 
They are further codified in the World Trade Organisation (WTO) Sanitary and Phytosanitary 
protection measures, to which WTO member states are bound. 
The above conclusions confirm that all possible risks that could be associated with GM tech-
nologies are inextricably linked with the resulting GMOs, not the techniques that yield them. It 
therefore follows that the traits of these organisms/products should be the trigger for regula-
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tion and not the processes/techniques used to create them. In addition to this risk-rational, a 
regulatory trigger based on products rather than processes also makes more practical sense 
in terms of:
•	  the same process/technique can yield GMOs/products with widely differing genetic traits 
and risk profiles;
•	  although ‘modern biotechnology’ processes/techniques may be used, the resulting or-
ganisms/products may be indistinguishable from conventional/natural organisms;
•	  processes evolve while the acceptable risk profile of products can be defined in terms of 
principle parameters that are less likely to change over time – a product focus can there-
fore ensure regulatory consistency;
•	  with a product risk management focus it is possible to define clear, durable risk thresholds 
(beyond which regulation is required) to help ensure regulations remain relevant and ap-
propriate. 
IMPorTAnT noTe
It is important to realise that the term ‘product’ in this context does not only refer to a final 
product/GMO, i.e. that which is eventually commercialised, but rather to any and every 
organism/GMO, which may be produced during any research and development (R&D) 
programme. The intention of using a ‘product-based’ regulatory trigger is therefore not to only 
regulate ‘final products’, i.e. to exclude early R&D work from regulation, or to try to completely 
detach techniques/processes from products, but rather to focus regulation, and associated 
risk management interventions on the most relevant hazard (potential source of harm).
Despite these apparent obvious conclusions regarding the advantage of a product-based 
approach and the product-based systems implemented by the first adopters of the technology 
such as the USA and Canada, many national biosafety regulatory frameworks have evolved 
to use the GM process as the trigger for regulation. The underlying philosophical reason for 
this is probably the persistent, apparent controversial nature of GMOs, which has resulted in a 
significant divergence between the perceived and science-based risks associated with these 
organisms and their products. Considerable pressure has therefore been placed on regulatory 
frameworks to adopt a precautionary approach and to be ‘all-inclusive’ in an attempt to 
manage this broad spectrum of risk perceptions and to inspire confidence. Historically, this 
philosophy, heavily influenced by the European perspective, also impacted negotiations 
at the CPB, which eventually adopted a process focus, i.e. “…genetic material obtained 
through the use of modern biotechnology”. The subsequent use of the CPB as the basis for 
the development of their national biosafety frameworks by many countries, contributed to 
the proliferation of process-based regulatory systems.
Although all policymakers and regulators are not in agreement that product-based systems 
have clear advantages to process-based systems, primarily in light of the possible legislative 
amendments that a new focus may require, there is growing support from risk assessors, 
technology developers and even regulators for an exclusive product-based approach 
(Marchant and Stevens, 2015, Van Eenennaam and Young, 2015, Huang et al., 2016, Sprink 
et al., 2016). NBTs now place even more emphasis on the advantages of a product or trait-
based system, since the boundaries between GM and non-GM techniques are becoming 
increasingly blurred and, in some cases, impossible to detect. NBTs therefore provide additional 
motivation to ensure regulatory frameworks are consistent, proportionate, evidence-based 
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and sufficiently robust to accommodate both existing and new technologies and agronomic 
practices as they arise.
It is important for policymakers to recognise that NBTs are already widely used in research, 
and that commercial applications have started to emerge. Regulatory frameworks should 
therefore adapt as a matter of urgency to be able to accommodate them (Lusser et al., 2012, 
2013). Policymakers should further realise that there are also possible costs associated with not 
introducing appropriate regulatory processes. These include inhibition of the development 
of potentially important applications that could contribute to addressing some of the key 
challenges facing agriculture, deployment of novel traits without appropriate consideration 
of risks when new products fall outside the remit of existing regulatory processes and additional 
costs arising from the need to detect particular types of novel products in traded goods. 
Key MeSSAGe
A product-based regulatory framework has distinct advantages over a process-based sys-
tem. Product-based regulatory triggers ensure an appropriate focus on the actual source 
of possible risks, i.e. the hazard, and enable the establishment of suitable, resilient regulatory 
parameters, which will remain relevant and appropriate irrespective of future technological 
developments.
6.4 The South African regulatory framework for GMos
In general, the principal reason for any regulation is to mitigate harm through risk manage-
ment. Regulation is, therefore, only triggered at a point beyond which explicit risk manage-
ment is required and the regulatory requirements should always be proportionate with the risk 
posed. In the South African context, the definition of a GMO in the GMO Act focuses on the 
‘unnatural’ character of the introduced genetic change/variation and therefore introduces 
‘unnatural genetic variation’ as the threshold beyond which risk should be managed/regu-
lated. In the Act’s definition of a GMO1, ‘unnatural’ could be interpreted as referring to either 
the way in which the genetic variation was introduced, i.e. the process – ‘artificial, human 
intervention’, or the nature of the resulting genetic material/GMO, i.e. the product – ‘genetic 
variation that could not conceivably have originated naturally’. 
When considering the exclusions of the GMO Act, i.e. mutagenesis, ploidy manipulations and 
somatic hybridisation, it is clear that human intervention/process is not considered an abso-
lute trigger for regulation, but rather the end result/product of the intervention. Moreover, 
although the excluded techniques can be used to artificially induce genetic variation, all 
possible resulting variation will be limited to modifications of only the endogenous genetic 
material – no exogenous genetic material is added and therefore variation that can conceiv-
ably also originate naturally. In contrast to this ‘induced endogenous’ genetic variation, GM, 
as contemplated in the Act, adds exogenous genetic material to the target genome, which 
results in genetic variation that could not have originated naturally based on sexual compat-
ibility and therefore introduces the possibility of novel risk, which should be regulated.
It is therefore evident that a GMO under the Act, i.e. “…an organism the genes or genetic 
material of which has been modified in a way that does not occur naturally…”, is defined in 
terms of its eventual genetic makeup and not the process through which it was established; 
1 “Genetically modified organism – means an organism the genes or genetic material of which has been modi-
fied in a way that does not occur naturally through mating or natural recombination or both, and ‘genetic modifi-
cation’ has a corresponding meaning”.
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GMOs being organisms whose genetic variation has been increased beyond that which may 
likely also occur naturally, through the introduction of exogenous genetic material. The GMO 
Act, therefore, establishes a ‘genetic variability threshold’ for regulation, aimed at only man-
aging the possible risks, associated with the introduction of genetic traits beyond those that 
may conceivably also originate naturally. Any induced genetic variation limited to what may 
conceivably also occur naturally, including any small insertions/deletions and recombina-
tions/transformations with sequences/genes from compatible organisms, therefore falls be-
low this genetic variation threshold and should not be regulated, as any risks this may pose 
are equivalent to those that also occur naturally. This natural genetic variation threshold is 
also prudent in light of the fact that these, even when induced using a bio-technique, will be 
undetectable/indistinguishable from natural variation, which will make regulation impossible 
to enforce.
When considering that the GMO Act has a product-based approach and that it establishes 
an appropriate threshold for regulation based on genetic variation, it is clear that the Act 
is sufficient to handle the regulation of all current and possible future techniques aimed at 
modifying the genetic material of living organisms. New genetic modification technologies, 
including NBTs, and all possible sub-sets thereof should be evaluated in terms of their ability 
to introduce novel risks (those that could not also conceivably arise naturally) within appro-
priate, well-defined parameters/limits to exclude/include them under the Act as a matter of 
principle or to be regulated on a case-by-case manner. Such an approach is also in line with 
Argentina’s trigger for the regulation of NBTs, e.g. “novel combination of genetic material” – 
the only formal pronouncement by a regulator on this issue thus far.
The preamble to the GMO Act states that its mandate is “to provide for measures to pro-
mote the responsible development, production, use and application of genetically modified 
organisms”. When considering the evolution and performance of the regulatory framework 
over the almost 20 years of its existence, it is fair to say that the great majority of its dealing 
adhered to this spirit. During this time the Act was for example amended to ensure align-
ment with other national and international legislation, regulations were amended to mitigate 
extraordinary circumstances and ex post risk management practices were implemented ef-
fectively. The South African regulatory framework for GMOs will therefore most likely be able 
to seamlessly integrate any possible changes necessitated by NBTs.
Key MeSSAGe
The GMO Act has a product-based trigger and establishes genetic variability beyond that 
which may occur naturally, as the threshold for regulation. Within this context the Act is 
appropriate and sufficient to regulate all current and possible future techniques aimed at 
modifying the genetic material of living organisms.
6.5  nBT risk Assessment
The risk assessment of GMOs is a structured, reasoned process, based on the analysis of 
scientific evidence, for considering the likelihood and consequence of harm occurring and 
is pro-actively used to facilitate decision-making regarding the development and use of 
GMOs. Biosafety risk assessments for GMOs focus on possible environmental and food/feed 
safety impacts. In addition, many countries also consider possible socio-economic impacts 
to ensure, cumulatively, the sustainability of a GMO before it is released for commercial 
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production. Generally, all these assessments are comparative, done on a case-by-case basis 
and consider the host and donor organisms, genetic modification and receiving environment. 
Although different countries may use different regulatory triggers, terminology and detailed 
frameworks, the underlying principles are consistent and universally accepted. 
NBTs refer to a wide and evolving range of techniques, including techniques that may 
permanently modify the target genomes and/or gene expression. In addition, these genetic 
changes may vary in a continuum from small mutations, indistinguishable from naturally 
occurring genetic variation, to the introduction of complex exogenous genetic pathways. 
In cases where the genetic traits of the resulting organism are impacted, the general risk 
assessment approaches, developed for GM crops, are in principle appropriate to address 
as well the potential risks of the NBT-derived organism (Eckerstorfer et al., 2014; Conka et 
al., 2016). Specifically, the principle of comparative case-specific risk assessment, takes into 
account the particular characteristics of the specific NBT event, e.g.: 
•	 the modifications to the genome due to the NBT;
•	  the introduction into the NBT-genome of DNA which is ordinarily not found in this crop spe-
cies;
•	 the traits generated by NBTs; 
•	 modifications to gene expression due to the NBT or the trait(s) introduced by use of NBTs.
Other risk assessment issues that may be of particular importance to NBTs include:
•	  Whether genomic modifications were introduced into the genome of a particular organ-
ism in the course of application of a NBT, and if so, which type of modification.
•	  Whether such modifications are present only transiently, in certain intermediate steps of 
the breeding process or present in a stable inheritable manner in the final breeding prod-
uct. An additional issue is whether such genomic modifications are present in all cells of 
the NBT or only in specific types of cells, e.g. somatic cells, reproductive cells or plant parts, 
e.g. transgrafting.
•	 Whether the NBT introduced non-native sequences into the context of the genome.
•	  The availability of sufficient knowledge on the modified genes and their function as well 
as experience with the traits generated by NBTs. This is also recognised in the concept of 
“history of safe use” which is an important element in the comparative risk assessment for 
GM plants.
•	  Verify whether available experience and data, e.g. those drawn from conventionally bred 
crops, are appropriate to address some of the risk assessment issues of particular NBTs.
•	  To be able to implement a comparative approach two considerations need to be taken 
into account:
o  The definition of an appropriate ‘unmodified’ comparator – typically a crop line with 
a similar genetic background, such as an isogenic line.
o Choice of a scenario for conducting the comparative approach.
Key MeSSAGe
GMO risk assessment has evolved over more than three decades into a robust framework 
that can be applied to any genetically engineered organism, irrespective of the techniques 
used as long as the principles of a case-by-case comparative risk assessment applies.
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6.6 GMo risk experience
GMO regulatory scrutiny is applied to individual ‘transformation events’ even when the 
same gene introduction has been evaluated many times previously, on the premise that the 
physical insertion of DNA into a genome could itself have potentially hazardous, unintended 
effects by interfering with the normal functioning of endogenous genes (Kessler et al., 1992.). 
Consequently, each time a given transgene is introduced into an organism, regulators 
consider that a new ‘event’ is created, which constitutes a unique product for the purposes 
of regulation, which in turn requires individual field testing, the preparation of a complete 
regulatory dossier and regulatory approval. 
The case for re-evaluating these regulatory requirements has been strengthened by more than 
two decades of experience (Conko et al., 2016). A review by Weber et al. (2012) concluded 
that unintended DNA-level changes that could occur from GM are no different from those 
that occur in plant genomes naturally, a finding that was later substantiated in a review by 
Schnell et al. (2015). Likewise, Steiner et al. (2013) observed that novel toxins not known to 
occur at the genus level have never been known to arise spontaneously during conventional 
breeding. These findings are consistent with the prediction of the 1989 NRC analysis which 
concluded that crops modified by molecular and cellular methods pose risks no different 
from those modified by classical genetic methods for similar traits.
Some examples of the application of NBTs to achieve a beneficial genetic modification and 
the possible risk management and regulatory implications are given in Appendix 3.
6.7 Conclusion
The regulation of NBT-derived organisms can be comfortably incorporated under the GMO 
Act and any potential risks can be effectively governed if:
(i)  the Act is interpreted as having a product-based trigger, i.e. the characteristics of the 
genetic change and resulting organisms; 
(ii)  genetic variation beyond that which may occur naturally is considered the threshold 
for regulation.
IMPorTAnT noTe
These two defining parameters, i.e. trigger and threshold, should always be interpreted in 
the same context, i.e. genetic variation beyond that which may occur naturally, refers to 
the actual genetic change/traits of the organism/product and does not relate to how they 
were introduced, i.e. the process.
This will, in effect, mean that the final genetic change becomes the primary indicator/trigger 
for regulation and the resulting organisms can simply be classified as either GMO or non-GMO 
and managed accordingly. If classified as GMO it will be regulated as legislated by the GMO 
and related Acts – i.e. the GMO status quo, if not, no regulation beyond that associated with 
conventional breeding will apply (Refer to Fig 7.1 and Table 7.2). 
If deemed necessary, this final classification can still be done on a case-by-case basis by 
regulators within the current regulatory framework, e.g. as part of a succinct ‘notification 
procedure’ to the Registrar of the GMO Act (Also see Section 7.2 and Fig 7.2). This will ensure 
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complete oversight without introducing excessive regulatory constraints on products that do 
not warrant risk management.
Within the South African context, no major legislative changes are considered to be necessary 
to accommodate NBTs or any possible future genetic engineering technologies. However, 
if the regulatory system is to ensure it remains fit-for-purpose, current and efficient, some 
significant issues will have to be addressed – including conceptual and operational issues 
related to definitions, exclusions, operational parameters, delegation of authority, standard 
operating procedures (SOPs), conformity to set time lines, etc. In addition, technical issues 
such as the type, quality and extent of the evidence and the identification of appropriate 
comparators required for different applications to ensure proportionate risk assessment and 
management will have to be considered, while allowing South Africans to benefit from these 
biotechnologies.
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ChapTer 7
general Conclusions 
and recommendations
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7.1  Introduction
At the time of drafting the GMO Act, it was generally understood that GMO refers to an or-
ganism into which exogenous genetic material was introduced using genetic engineering 
techniques. In other words, the introduction of genetic variation beyond that which may also 
occur naturally, which consequently clearly implies a product-based regulatory trigger (Pers. 
comm. J Morris, M Koch and D Keetch). Moreover, organisms developed using techniques 
which are limited to increasing only endogenous genetic variation, e.g. mutagenesis, ploidy 
manipulation, somatic hybridisation, conjugation, transduction, transformation and “any oth-
er natural process”, were explicitly excluded from regulation (GMO Act). However, over time 
this distinction has become blurred, both in terms of “regulatory intent”, i.e. a product vs. 
process-based regulatory trigger, and the continuum of possible genetic interventions that 
are now possible using newly developed techniques.
The concepts which guided the formulation of the original GMO definition and the list of 
exclusions in the GMO Act are still relevant and applicable to the questions we face now in 
2017. The principle that organisms should be regulated according to the risks they may pose 
based on their modified genetic composition should remain the prime consideration. Ge-
netic variation that may also occur in nature does not pose biosafety risks beyond that which 
may also occur naturally and therefore does not warrant regulation (Fig 7.1). There is also the 
practical requirement to be able to detect those organisms that are defined as GMOs to al-
low effective regulation. Reliably detecting organisms that might be indistinguishable from 
naturally occurring mutants presents an insurmountable challenge for enforcing compliance.
 
Based on the findings of this study, the following conclusions and recommendations are made. 
It is the panel’s overall recommendation that these conclusions and recommendations should 
be considered and discussed by the Executive Council of the GMO Act in order for them to 
refine and implement them as appropriate. It is critically important to ensure that South Africa 
maintains and further develops a fit-for-purpose regulatory framework for genetic engineering 
technologies to optimally balance the requirement for safe, sustainable products and the 
need for a research and development environment conducive to bio-innovation. Failure to 
adapt the current regulatory procedures to fully enable the responsible utilisation of NBTs 
could have a negative impact on research and innovation in South Africa as contemplated 
in the Bioeconomy Strategy. 
7.2   Proposed regulatory framework for nBTs (and other Genome Modifying Techniques) 
in South Africa
South Africa has a robust GMO regulatory framework that has been used for more than 20 
years to effectively regulate these organisms. The experience and expertise built up over this 
period should form the basis for the discussion regarding the regulation of NBTs, bearing in 
mind that:
(i)  Regulation, where appropriate, should be based on sound scientific principles and be 
proportionate to the potential risks that are being managed. 
(ii)  The actual source of the risk that should be managed is the NBT-derived product, not 
the process through which it was developed (Fig 7.1). In addition, the same technique 
can often yield a wide variety of different products or different techniques can be 
used to develop the same product. A product-based regulatory trigger is therefore 
the rational choice.
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IMPorTAnT noTe
It is important to understand that although some techniques can be sub-categorised to 
define only a very specific genetic intervention-type, e.g. ZFN-1 that yields only small NHEJ 
indels, which could principally be excluded from regulation “as a technique”, the relevant 
basis of that decision is still the induced genetic change/characteristics of the resulting 
product and not the technique (Discussed in detail in Section 6.3).
(iii)  Induced changes to genomes need to be evaluated in light of the inherent natural 
variability of genomes and their associated  impacts on the biosafety profiles of the 
related organisms. Moreover, it is not prudent to regulate NBT-derived products that 
are indistinguishable from products that could conceivably also be produced via more 
traditional methods as these products will not differ in their biosafety profiles.
(iv)  The current definition of a GMO in the GMO Act can comfortably accommodate the 
above considerations regarding NBTs and clearly establishes genetic variation – be-
yond that which may occur naturally – as the threshold for regulation. 
(v)  South Africa’s current regulatory framework for GMOs could therefore, with only minor 
updates to the GMO Act’s Regulations and guidelines, be used to effectively regulate 
NBTs and all possible future genome modifying techniques.
(vi)  The regulation of products derived from NBTs should be rational, clear and consistent in 
order to enable research institutes and the industry to adequately plan for the develop-
ment and commercialisation of any regulated NBT products.
(vii)  Internationally, governments should seek to harmonise their approach towards NBTs 
and avoid the unnecessary regulation of products developed through NBTs and other 
genetic engineering techniques.
As argued in Chapter 6, the products of various techniques which increase endogenous ge-
netic variation have never been regulated under the GMO Act, because they are considered 
an extension of natural processes – their greatest possible biosafety risk impact will always be 
limited to what may also occur naturally. In other words, induced mutagenesis, in contrast to 
transgenesis, can never introduce genetic variation or risks that could not also originate natu-
rally. In addition, recombination, which is also excluded from regulation under the GMO Act, 
is defined as any “shuffling of possible parental DNA”, i.e. all possible combinations of genetic 
material from sexually compatible species. It therefore follows that neither the (induced) mu-
tagenesis of a defined genome, nor the (induced) recombination of genetic material within 
sexually compatible species, e.g. cisgenesis, can introduce risks that could conceivably not 
also originate naturally – and the resulting products should therefore not be regulated. 
The implications of this approach are that:
(i)  Genetic change becomes the primary indicator and trigger for regulation – as it should, 
because it is the root source of risk.
(ii)  Biosafety risk is simply divided into two categories – that which may occur naturally and 
that which may not.
(iii)  Regulation/risk management is implemented only for organisms above this threshold of 
natural biosafety risk.
(iv)  The GMo Act remains an adequate instrument for the regulation of all possible geneti-
cally engineered organisms. 
(v)  Regulated organisms are defined as GMOs, based on the GMO Act’s definition of a 
GMO, while the rest are non-GMO.
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These points are summarised schematically in Figure 7.1.
figure 7.1 A schematic summary of the basis for the regulation of GMOs
It is important to note that although the GMO Act’s mandate is clearly limited to managing 
the possible risks associated with genetic changes that may not occur naturally (GMOs), 
other relevant legislation, such as the Plant Improvement Act (Act 53 of 1976) and the Na-
tional Environment Management Act (Act 107 of 1998), may still apply to non-GMOs gener-
ate through NBTs. Collaboration between the various regulators and harmonisation of all 
relevant regulatory instruments should therefore always remain a priority to ensure, overall, 
regulations are fair, prudent and consistent and do not introduce unnecessary overlap, 
inefficiencies and/or bias.
Within the context of this suggested framework, the final decision on whether an organism is a 
GMO or not, and therefore subject to regulation under the GMO Act or not, can be reached 
by asking only a few pertinent questions. These can be organised into a simple decision tree 
as proposed in Figure 7.2. This decision tree also permits developers to pro-actively anticipate 
the applicability of GMO legislation at the design stage of product development, to allow 
appropriate adjustment if required.
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figure 7.2 Proposed NBT decision tree for determining whether a specific NBT, or any other genetic 
engineering organism, should be subjected to regulation under the GMO Act or not 
In practice, all relevant NBT products/lines could be subjected to a succinct “notification pro-
cedure” under the GMO Act, which requires the submission of the basic information required 
to answer the questions in the decision tree. Such a notification procedure will also introduce 
a mechanism which enables a case-by-case regulatory approach/decision-making by the 
EC of the GMO Act and appropriate oversight without introducing an excessive regulatory 
burden. 
Finally, the likely regulatory outcome for specific products of the various NBTs assessed in this 
study, based on the proposed product-based regulatory trigger and unnatural genetic vari-
ation threshold, are summarised in Table 7.1.
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Table 7.1 The likely regulatory outcome for specific products of various NBTs based on the proposed 
product-based regulatory trigger and unnatural genetic variation threshold
nr Genetic change Technique used regulated as a GMo?
1 Small, targeted and untargeted inserts or deletions based on non-homologous end joining (NHEJ)
Site-directed nucleases 
(SDNs)1, mutagenesis No
2
Small, targeted inserts or deletions based on homolo-
gy-directed repair (HDR)
SDNs, oligonucleotide-
directed mutation 
(ODM)
No
3 Large, targeted genomic deletions SDN pairs No
4
Targeted insertion of homologous, functional gene 
sequences, including genes and/or regulatory se-
quences (cisgenes)
Cisgenesis using SDNs
No
5
Targeted insertion of reorganised, homologous, 
functional gene sequences, including genes and/or 
regulatory sequences (intragenes)
Intragenesis using SDNs
Yes
6
Targeted and untargeted insertion of heterologous, 
functional gene sequences, including genes and/or 
regulatory sequences
Transgenesis, using 
“conventional GM 
technology” or SDNs
Yes
7 Epigenetic modifications RNA-dependent DNA Methylation No
8 Null segregants Reverse breeding No
9
Transgrafting – combination of a GM rootstock and a 
non-GM scion or vice versa
GMO part and its 
products Yes
Non-GMO part and its 
products No
1e.g. ZFNs, MNs, TALENs & CRISPR/Cas
7.3 final Conclusion and recommendation
Regulation should only be triggered at a point beyond which explicit risk management is re-
quired and the resulting regulatory requirements should be proportionate to the risk posed so 
as not to unduly impact on innovation. South Africa already has a robust and effective GMO 
regulatory framework that is able to accommodate the regulation of NBT-products and, in 
fact, the products of any genome modifying techniques that may still be developed in future. 
In order to do so the GMO Act’s:  
(i) trigger should be interpreted as being product-based; 
(ii)  regulatory threshold should be interpreted as being genetic variation beyond that 
which may occur naturally.
The panel is of the opinion that the implementation of such an approach will provide effec-
tive and appropriate oversight to ensure the safety and sustainability of all relevant prod-
ucts, without unduly impacting on innovation. It can also be implemented relatively quickly 
and easily, because it is based on already established legislation. Finally, although very few 
countries have officially implemented NBT regulations, the likely regulatory outcomes of the 
proposed approach align very well with the consensus discussions of other international 
experts.
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Dr Groenewald is the Executive Manager of Biosafety South Africa, a national biosafety plat-
form initiated by Department of Science and Technology. Biosafety South Africa supports 
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biosafety research to help ensure the safety and sustainability of biotechnological products. 
He has a PhD in plant biotechnology and has over 20 years of experience in research and de-
velopment, teaching, project management, entrepreneurship and business development. 
His research career has focused on aspects of plant molecular physiology, biosafety, tissue 
culture, molecular biology and biochemistry, and he has authored several peer-reviewed 
papers and patents on these subjects. Prior to joining Biosafety South Africa, he worked at 
Stellenbosch University. He has previously also worked at the South African Sugarcane Re-
search Institute and has been a visiting researcher at the Texas Agricultural & Medical Uni-
versity, Weslaco, USA, the Max Planck Institut für Molekuläre Pflanzenphysiologie and Golm, 
Germany, and the Commonwealth Scientific and Industrial Research Organisation (CSIRO), 
Plant Industry, Brisbane, Australia.
Dr eugenia Barros 
Dr Barros has a PhD in microbiology from the University of Cape Town and she is a Principal Re-
searcher in the Biosciences Unit at the Council for Scientific and Industrial Research (CSIR). She 
has led many scientific projects in the field of molecular biology and has been instrumental 
in applying some of her research outcomes in the agricultural and food sectors. She has also 
been at the forefront of plant-made therapeutic antibodies through a collaborative project 
with European laboratories and has scaled-up the production of an HIV-AIDS monoclonal 
antibody. Her research interests’ focus on the development of molecular markers linked to 
gene coding for important traits using cDNA-based marker technologies. She has more than 
ten years’ experience in molecular marker technology in cereal crops and eucalyptus.
Dr Kingston Mashingaidze 
Dr Mashingaidze is Research Team Manager for Plant Breeding at the Agricultural Research 
Council’s (ARC) Grain Crops Institute in Potchefstroom. He is also the South African Country 
Coordinator and Principal Investigator of Water Efficient Maize for Africa (WEMA) and the 
Improved Maize for African Soils (IMAS) project. 
Prof Iqbal Parker
Prof Parker is the former Director of the International Centre for Genetic Engineering and Bio-
technology (ICGEB) Cape Town Component. He is currently a Professor at UCT. Previously he 
was the Head of the Division of Medical Biochemistry and Director of Research in the Health 
86 THE REGULATORY IMPLICATIONS OF NEW BREEDING TECHNIQUES
Science Faculty at the University of Cape Town. He obtained his PhD in biochemistry in 1979, 
completed a postdoctoral fellowship with Gary Stein in the USA and returned to join the De-
partment of Medical Biochemistry in 1981. He was President of the South African Society of 
Biochemistry and Molecular Biology (1998 – 2001), and founder Secretary-General of FASBMB 
(the Federation of African Societies of Biochemistry and Molecular Biology) from 1996 to 2003. 
He is a Founder Member of the Academy of Science of South Africa and served as General 
Secretary from 2000 – 2004 and Vice- President from 2010 to 2016. He served on the internation-
al jury panel for the Loreal/UNESCO Awards for Women in Science for the period 1997 – 2002. 
In 2006 he was elected to the Executive Committee of the International Union of Biochemistry 
and Molecular Biology and has served as the Chair of the Committee on Symposia. In 2004 he 
was awarded the South African Society for Biochemistry and Molecular Biology Gold Medal 
for his contributions to biochemistry and the National Science and Technology Forum (NSTF) 
award for Outstanding Contributions in Science, Engineering and Technology in 2003.
Dr James Southern
Dr Southern is currently a consultant to the biotechnology industry, Advisor to the National 
Medicines Regulatory Agency (Biological Medicines, Clinical Trials and Pharmacovigilance) 
and temporary evaluator for WHO Prequalification of Vaccines. He is also the Chair of the 
Developing Countries Vaccine Regulators’ Network (DCVRN). He has worked in all aspects of 
vaccine development, production and control between 1968 and 2000 and he has been a 
member of the Biological Weapons Working Group reporting to the Non-Proliferation Council 
since 1993, and was a member of the Non-Proliferation Council from 1994 to 2009. He advises 
the Biosafety Directorate of the Department of Agriculture on the safety of medicines incor-
porating genetically modified organisms.
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appendix 3 
examples of the application of 
new breeding Techniques
The following four studies illustrate the use of a NBT to achieve a beneficial genetic modifica-
tion and the possible risk management and regulatory implications.
1 Insect-resistant and herbicide-resistant cotton 
The introduction of Meganuclease and repair DNA for homologous insertion of two genes into GM 
cotton (D’Halluin et al. 2013). 
Host: GM Cotton GHB119
Phenotype: Glufosinate tolerant (bar); Lepidoptera Resistent (cry2Ae)
Technique: Meganuclease 
Biolistic introduction of Meganuclease and repair DNA for homologous insertion 
of two genes – epsps and hppd.
Background: Herbicide-tolerance and/or insect-resistance is the most widely used GM traits in 
cotton. Different herbicide-tolerance and insect-resistance genes with different 
modes of action are needed to provide for future combined, broad coverage 
weed and pest control. In addition to herbicide-tolerance and insect-resistance 
traits, there are several agronomic and quality traits being developed for mul-
tiple-trait introgression in cotton and other crop plants, including disease-resist-
ance, abiotic stress-tolerance, yield enhancement and quality traits. Combin-
ing two or more traits in one variety can be performed either by conventional 
breeding stacks or by molecular trait stacking in a single transgene locus using 
a transformation vector carrying multiple-trait genes. With both technologies, 
the logistical challenges increase with the number of trait genes to be stacked. 
Either large breeding populations have to be screened to identify those indi-
viduals in which all trait genes are retained or large numbers of transformants 
have to be screened to identify the one expressing all traits as desired. Targeted 
molecular trait stacking could overcome many of these challenges by targeted 
insertion of the additional trait genes in close genetic vicinity of an already exist-
ing transgene locus.
In this study, the feasibility of precise targeted integration of transgenes at an 
elite locus in cotton is demonstrated. This was possible through the combina-
tion of targeted DNA cleavage by nucleases with tailor-made specificities and 
HR-mediated repair of the DSB by naturally occurring DNA repair mechanisms. 
Targeted molecular trait stacking will facilitate faster and economical trait intro-
gression.
Possible risks: Mutations introduced at off-target genomic locations sharing homologous se-
quences with the target site.
Unintended modification due to methods applied during transfection and re-
generation.
Unintended effects associated with GM modification that are introduced in in-
termediate steps.
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2 Herbicide-tolerant rice 
The introduction of RNA/DNA oligonucleotides into rice plants to confer resistance to acetolactate 
synthase (ALS)-inhibiting herbicides. (Okuzaki and Toriyama, 2004.)
Host: Rice
Phenotype: Resistance to sulfonylurea and imidazolinone herbicides
Technique: Particle bombardment by introducing chimeric RNA/DNA oligonucleotides de-
signed to target the independent codons for Pro-171, Trp-548 and Ser-627 of the 
endogenous rice acetolactate synthase (ALS) gene so it would confer resist-
ance to ALS-inhibiting herbicides.
Background: Chimeric RNA/DNA oligonucleotides (COs) have been used to cause site-spe-
cific base changes in chromosomal targets in mammalian and plant cells COs 
consist of 68 synthesised oligonucleotides which have a DNA ‘mutator’ region of 
five nucleotides complementary to the target site flanked by 20-O-methyl RNA 
bridges of eight to twelve nucleotides each. This DNA ‘mutator’ region includes 
a mutation that is introduced into the endogenous gene. The first use of COs 
to cause site-specific base changes in plant cells was reported in maize and 
tobacco. In both cases, gene targeting was directed towards generating base 
changes that resulted in a chemically selectable phenotype. The targeted gene 
was an acetohydroxyacid synthase (AHAS) gene in maize and an acetolactate 
synthase (ALS) gene in tobacco. Both ALS and AHAS are the first common en-
zymes in the biosynthetic pathway of branched-chain amino acids, leucine, iso-
leucine and valine, and mutations of specific amino acids in these proteins have 
been known to confer resistance to sulfonylurea and imidazolinone herbicides. 
In this study, the feasibility of CO-directed gene targeting was examined in rice. 
Three COs were designed to introduce single-point mutations in the rice ALS 
gene. Five plants resistant to ALS-inhibiting herbicide were selected, and the 
nucleotide sequence of the ALS gene of each was determined. Specific con-
versions were detected at the targeted bases. The ALS gene of rice was chosen 
as a target gene. The ALS gene was shown to exist as a single-copy gene in rice. 
CO-directed gene targeting is less complicated in rice than in tobacco and 
maize because tobacco and maize have an allotetraploid genome, and thus 
two copies of ALS genes.
In the current study, precisely the expected alterations were detected in all five 
plants examined. The results indicate that CO-directed gene targeting is fea-
sible in rice and creates opportunities for basic studies of functional genomics 
and the manipulation of agricultural traits in rice.
Possible risks: Mutations introduced at off-target genomic locations sharing homologous se-
quences with the target site.
Potential expression of fusion-proteins for some types of knock-out mutations.
Unintended modification due to methods applied during transfection and re-
generation.
Unintended effects associated with GM modifications that are introduced in 
intermediate steps.
Unintended effects, e.g. position effects, associated with introduced transgenic 
constructs.
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3 Targeted gene knockout 
Demonstration of CRISPR-Cas9/gRNA-mediated targeted gene modification in Arabidopsis, tobac-
co, sorghum and rice. (Jiang et al., 2013)
Host: Rice
Phenotype: Resistance to bacterial blight  
From the protoplast cells, it can generate a GM plant
Technique: Cas9/single guide RNA (gRNA) system 
Transient expression in rice protoplast cells with Cas9/gRNA 
The target of the modification generated a change in the promoter region of 
genes (OsSWEET14 and OsSWEET11)
Background: The clustered regulatory interspersed short palindromic repeat (CRISPR)/CRISPR-
associated protein (Cas) system, has evolved from studies of a set of related de-
fence systems that a number of bacteria use in warding off invasion by viruses and 
foreign DNA molecules that enter the cell. In cells containing type II CRISPR/Cas 
systems that successfully ward off invading viruses or foreign DNAs, 20-bp snippets 
of the invading DNA sometimes can be incorporated as short palindromic repeats 
into the CRISPR region of the bacterial chromosome. During future assaults, de-
struction of invading DNA is achieved by an RNA-directed process in which RNAs 
encoded by the short palindromic repeats of the CRISPR region are transcribed 
into CRISPR RNA (crRNA) segments that are processed into short, functional RNA 
fragments with the aid of trans-activating RNA (tracrRNA). Once processing is 
complete, both crRNA and tracrRNAs become associated with a Cas protein. 
The Cas protein contains two nuclease domains that can cleave each strand 
of DNA when DNA becomes associated with the Cas/crRNA/tracrRNA complex. 
This complex is guided to viral DNA or exogenous foreign DNA by hybridisation of 
a 20-bp portion of the crRNA to one strand of the invading DNA. Action of the 
two independent nuclease domains within Cas results in a double-stranded DNA 
break (DSB) at a site on the foreign DNA just upstream of a protospacer adjacent 
motif (PAM) composed of a few (2–5) nucleotides depending on the CRISPR/Cas 
system involved. The type II CRISPR/Cas system most widely used for gene editing 
is derived from Streptococcus pyogenes and has the advantage of possessing a 
PAM recognition sequence of only two nucleotides in length (GG). This allows for 
creation of numerous ‘guide’ RNAs (i.e. crRNAs) for any particular gene because 
of the usually abundant presence of GG sequences in most genes. 
The CRISPR-Cas9 system and the simpler Cas9/gRNA system have proven suc-
cessful in gene disruption, gene activation/repression and genome editing in 
several cell types and organisms [e.g. in bacteria, yeast, zebra fish, fruit fly and 
human cells . However, to date, there are no reports of successful expression of 
the CRISPR/Cas system in plants or plant cells. In this report, three slightly different 
versions of the Cas9/gRNA system delivered by Agrobacterium tumefaciens or 
polyethylene glycol (PEG)-mediated transfection are demonstrated to be func-
tional in Arabidopsis and tobacco (dicots) and rice and sorghum (monocots).
Data presented in this report provide unambiguous evidence that the Cas9/gRNA 
system for targeted gene modification functions in higher plant cells. Expression 
of Cas9 and gRNA genes in two dicot species, Arabidopsis and tobacco, led to 
targeted cleavage of a non-functional GFP gene, mutagenesis by NHEJ DNA 
repair (verified by DNA sequencing) with restoration of a correct reading frame 
to the GFP gene and production of a strong green fluorescence in transformed 
leaf cells. 
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Methods, strategies and gene constructs developed in this study should be ap-
plicable to a wide range of higher plants. Indeed, successful development of the 
Cas9/gRNA system for targeted gene modification and genome editing holds sig-
nificant promise for advancing fundamental knowledge of plant biology as well 
as for creating crop plants with valuable new agronomic, nutritional and novel 
traits for the benefit of farmers and consumers.
Possible risks: Off-site effects – Mutation may be introduced at non-specific loci with similar, but 
not identical, homology to the target sites
Mosaicism – plants with a mutant allele in only some of their cells may be pro-
duced, because the nucleases may not necessarily cut the DNA at the correct 
stage of development
Multiple alleles – healing of the nuclease cleavage site by non-homologous end 
joining may produce plants with different mutations from the same targeting con-
structs, requiring genome sequencing to verify the nature and position of the spe-
cific mutation.
4 Red-fleshed apples with high level of antioxidants 
The development of two methods for the generation of cisgenic apples. (Krens et al., 2015)
Host: Apple
Phenotype: Red-fleshed apple fruits with an appealing red appearance and an increased 
level of anthocyanin-based antioxidants
Technique: Cisgenesis
Agrobacterium tumefaciens 
The construction contains MdMYB10 (gene from a red-fleshed apple coding for 
a transcription factor involved in regulating anthocyanin biosynthesis), flanked 
by its native promotor and terminator.
Background: There is a great need for faster breeding tools, especially in woody plant spe-
cies or others with a long generation time, and in vegetatively propagated het-
erozygous crops such as apples, pears, potatoes, and tulips. Crosses with ‘wild’ 
relatives require several rounds of back-crossing with the elite parent in order 
to get rid of undesired, negative traits originating from the wild parent. In ap-
ple, true back-crosses cannot be done because of self-incompatibility, adding 
to the complexity of apple breeding. So, once a high quality, elite variety has 
been bred after many years, a new crossing for the introduction of a single trait 
will make it disappear without a chance of ever being able to breed a simi-
lar variety again. Introduction of a single trait in an elite variety maintaining all 
good characteristics through GM, therefore, seems a perfect solution for these 
crops. However, the perceived risks of GM have severely hampered large-scale 
applications of this technology in apple or other food crops. To accommodate 
to some of the major objections, with the aim of reducing as much as possible 
public concerns and biosafety issues, the concept of cisgenesis was formulated 
in which the introduction of desired traits is still achieved by GM as a tool but the 
origin of the gene(s) is from sexually compatible plants, and the structure of the 
gene with native promoter, terminator and exons and introns is as it is present 
within the related donor plant. No foreign genes are present in the final product, 
particularly no antibiotic resistance genes of bacterial origin. 
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Background: There are three methods to generate cisgenic plants. One is to avoid the use 
of any selection genes of any other source than the recipient organism (e.g., 
apple) whatsoever. Second is to use two separate T-DNAs, one delivering the 
necessary selectable marker genes and the other carrying the genes-of interest 
from cross-compatible species followed by segregation of these two T-DNAs in 
the progeny. The third method is to use excision of selectable marker genes by 
inducing recombination. 
In this study the development of new cisgenic apple lines was achieved by 
recombination-induced excision of non-apple gene sequences from the T-DNA 
of the transgenic lines. 
A new series of cisgenic apple lines were generated using an entirely differ-
ent approach. Using the apple MYB transcription factor gene, MdMYB10, car-
rying the natural rearrangement in the promoter as found in red-coloured, 
red-fleshed apple varieties originating from var. “Niedzwetzkyana”, a minimal 
vector was constructed containing within the T-DNA borders only this MdMYB10 
gene, flanked by its native promoter and terminator. Red, cisgenic “Gala” and 
“Junami” apple lines were produced by selecting solely on anthocyanin pro-
duction and red staining of callus, shoots, and plants.
This paper contributes to the accumulating evidence that cisgenic crops are 
similar to conventionally bred crops, as was already concluded for hazards as-
sociated to both breeding methods by the EFSA Panel on Genetically Modified 
Organisms.
Possible risks: Proteins may be expressed that have never been part of the human or animal 
diet.
Increased expression of endogenous plant genes may affect the food and feed 
safety via altered biochemical properties.
Disruption of existing ORFs or creation of new ones due to random insertion of 
the cisgene in any part of the genome which in turn may lead to changes in the 
chemical composition of the plant
Due to position effects, the expression of the cisgene may differ from expression 
of the endogenous gene in its natural genomic position.
Insertional mutagenesis (e.g. deletions, rearrangements) may occur at the inser-
tion site of the cisgene.
As transformation methods usually are applied in cell cultures unintended 
changes in the plant genome may occur as a result of the in vitro culture.
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